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ABSTRACT
Staphylococcus aureus nasal carriage (SANC) is largely asymptomatic, but presents a risk of
autoinfection and dissemination to new immunocompromised hosts. SA disease states range
from mild cutaneous infections to life-threatening bacteremia.

Historically utilized rodent

models do not naturally carry SA in the nose, are insufficient in longitudinal SANC
experimentation, and lack immune factors that are vital in human clearance of SA. The nasal
passages of non-human primates are similar anatomically and histologically, and reproductive
mucosal studies have shown similar immune responses to pathogens and human-relevant
microbial profiles. Seventeen captive pigtailed macaques (Macaca nemestrina) were found to
naturally carry SA in the nose and pharynx, while topical mupirocin ointment effectively
decolonized SA, similar to humans.

Colonization was established with a human-relevant

inoculum of 104 SA CFUs per nostril in four independent experiments, including with a human
isolate (ST398). Autologous and non-autologous macaque strains were carried similarly in load
and duration, each surviving over 40 days. Animals that cleared SA showed a rapid neutrophilic
innate response, with up-regulation of IL-8, MCP-1, and IL-1β following inoculation, as
observed in human hosts. Assessment of the nasal microbiome of pigtailed macaques and
humans demonstrated similar relative abundance of the most prevalent genera: Staphylococcus,
Corynebacterium, and Acinetobacter. Collectively, these multidimensional analyses provide
evidence that the pigtailed macaque is a novel physiological model of human SANC that may be
useful for testing novel SA decolonization strategies.
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CHAPTER 1: INTRODUCTION
Staphylococcus aureus Nasal Carriage and Population Dynamics
Staphylococcus aureus (SA) is a gram-positive, coagulase-positive, clustered cocci that is
a part of normal skin flora of a wide range of mammalian hosts, including humans [1, 2]. SA
transiently colonizes healthy human skin; however, a myriad of common SA disease states put
pressure on our healthcare system, ranging from mild skin and soft tissue infections (SSTIs), like
furuncles, boils, and impetigo, to life-threatening infections, like toxic shock and scalded skin
syndromes, endocarditis, and bacteremia [3]. These are more likely to occur in those who have
weakened immune systems, such as the elderly, newborns, those with preexisting
immunocompromising conditions, and in close-contact populations with less than ideal
sanitation, like prisons, military bases, nursing homes, hospitals, and schools [4, 5]. Since the
widespread, and often unnecessary use of antibiotics began, SA has rapidly evolved resistance to
the majority, like penicillin, methicillin, and vancomycin, as well as evolution of multi-drug
resistant strains [6]. Antibiotic susceptible and resistant strains of SA are recognized as the most
relevant nosocomial pathogen, easily spread through passive contact, often from healthcare
worker to patient [7, 8]. This increases the duration of hospital stays, co-morbidities, and deaths
[9, 10], driving up the cost of healthcare.

Staphylococcus aureus alone accounts for

approximately 25% of nosocomial infections, with a great majority of these post-operative
infections [11], which places a heavy burden on the healthcare field, increased costs of medical
treatment, and extended hospital stays.
The main ecological niche of SA in the human host is the moist mucosa of the anterior
nares, surviving well in low-nutrient and increased salinity of nasal fluids. Introduction to the
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nose is typically through fomite-hand-nose, due to the ability of SA to survive long-term on
inanimate surfaces [12].

Staphylococcus aureus nasal carriage (SANC) is a largely

asymptomatic state, even in many cases of methicillin-resistant strains, only creating a problem
when the host becomes immunocompromised due to illness or defect. At any point in time,
Staphylococcus aureus persistently colonizes the nasal passage of 25-30% of healthy adults on a
world-wide scale [13, 14], and up to 80% intermittently [15]. Nasal carriage is associated with
increased rates of carriage at extranasal sites, such as the pharynx, hands, perineum, etc. through
passive contact of the hands with the face [8]. Also colonized are many companion animals like
dogs [16], and large domesticated livestock such as cattle and pigs [2, 17], and humans can
acquire the same strains through associating with animal carriers.

SA nasal carriers have

historically been categorized into one of three groups based on frequency of SA detection during
longitudinal studies: persistent, intermittent, and non-carriers [18]. Categorization of carrier
types is inconsistent between studies, especially from different countries, due to differences in
protocols and in experimental limitations. Determined through longitudinal nostril swabs of
human subjects, the nostrils of persistent carriers constantly contain detectable levels of SA when
cultured, intermittent carriers will clear SA to undetectable levels and recover it, and rare noncarriers will not swab positive for SA at all [2]. It has been recently suggested that only two
categories really exist, persistent and intermittent [2, 19], since it is expected that those that are
classified as non-carriers are harboring SA below culturable detection limits. SA is ubiquitous,
and humans are colonized on the skin at birth from the mother [20], so the likelihood for a
person to never nasally carry SA is slim. Current knowledge has not fully explained why some
healthy humans carry SA persistently, intermittently, or seemingly not at all, but what is known
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is that SANC is influenced by highly complex interactions between SA genetics, host innate and
adaptive immunity, environmental factors, and nasal microbiome biodiversity and interference.

Bacterial Determinants of Staphylococcus aureus Nasal Carriage
Staphylococcus aureus is very adept at persisting in the nostrils, regardless of its low iron
and nutrient availability and high salt concentration, and despite the presence of antimicrobial
peptides produced by nasal epithelial cells and commensal bacteria.

The nasal passage is

complex, with epithelium that transitions from the moist anterior portion characterized by
keratinized stratified squamous cells, hair follicles and various glands, to pseudostratified
columnar cells and a heavy mucous layer that is rapidly turned over by cilia and replaced [21].
Prior studies have determined that in human SA nasal carriers, the heaviest concentrations are
localized in the distal portion of the anterior nares lacking cilia [21, 22]. Colonization of SA in
the anterior nares relies upon very specific interactions between several SA surface proteins and
protein components synthesized by keratinized cells [23].

Clumping factor B (ClfB) is a

Staphylococcal surface adhesin that is mainly responsible for SA colonization, specifically
binding to loricrin, a protein expressed by keratinocytes to protect the exterior-most barrier of the
nasal mucosa [17]. Most disease states of SA involve these extracellular interactions with cells
or biofilm formation, but evidence has accumulated that suggests that SA can evade the host
immune system by inducing its own internalization by a zipper-type mechanism [24]. This
internalization allows SA to persist and multiply, or induce host cell death through production of
pore-forming toxins [24], releasing cellular contents and further increasing inflammation at the
site of infection.
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Staphylococcus aureus possesses 200-300 virulence factors, but few mechanisms are
understood, especially when it comes to nasal carriage, as nasal carriage strains are rarely
virulent. Once SA has adhered to the exterior surface of keratinized stratified squamous cells, it
has to evade neutrophils recruited by the host’s innate immunity as the first line of defense [25].
Staphylococcal protein A (SpA) is a multifunctional surface protein that binds Immunoglobulin
G (IgG) across the bacterial surface in an incorrect orientation to prevent recognition as another
method of evading neutrophil recognition, among other inflammatory functions [26]. Specific G
protein-coupled receptors on the surface of neutrophils recognize concentration gradients of
various small proteins that are released during SA opsonization or protein synthesis byproducts
[27]. These concentration gradients in addition to pro-inflammatory proteins produced by host
cells recruit resident neutrophils from surrounding tissues to the site of infection, however
diapedesis can be inhibited at several points along the neutrophil’s route by several virulence
factors that block interactions between receptors on the neutrophil and endothelial cells [27].
Clearance of SA from the nasal mucosa relies on a rapid and robust neutrophilic response, and
recent studies suggest that the nasal environment and host innate responses are primarily
responsible for allowing nasal carriage rather than bacterial factors [28].

Host and Environmental Determinants of Staphylococcus aureus Nasal Carriage
Prior studies have suggested that nasal carriage is determined less by strain characteristics
of the bacterium itself, but influenced heavily by host and environmental factors [28, 29]. SA is
highly adept at rapidly adapting to fluctuations in the nasal environment due external influences
such as change in climate, diet and health of the host, AMP concentration in the nasal fluid,
oxygen availability, and more. SANC risk factors like HIV, Type II diabetes, cancer, prolonged
4

hospital stays, and many others alter the nasal mucosal environment and decrease the ability of
the host’s immune system to respond appropriately to SA, increasing the likelihood for SA to
establish colonization in the nose and lengthen duration of carriage [5, 30].
Mucosal innate immunity is a group of processes involving receptors and effector
proteins that within minutes to hours of a detected threat activates to protect the host from a
potential infection. Keratinocytes on the epithelial surface of the anterior nares synthesize the
keratinous protective layer in the skin and act as immunological surveyors, producing proinflammatory proteins such as cytokines and chemokines, and up-regulating their constitutive
production of β-defensins when SA is sensed [31], representing the first line of defense against
pathogen invasion [32]. Adherence to nasal epithelial cells allows detection of SA through
pattern recognition receptors (PRRs) on the cell surface, principally Toll-like Receptor-2 (TLR2) in conjunction with additional TLRs [33].

TLR-2 forms heterodimers with TLR-6,

recognizing a conserved gram-positive bacterial cell wall component, lipoteichoic acid (LTA),
triggering an intracellular cascade that results in mitogen-activated protein kinase and nuclear
factor kappa-light-chain-enhancer of activated B cells (MAPK, NF-κB) mediated transcription of
pro-inflammatory cytokines and co-stimulatory molecules to further activate innate and adaptive
immunity [34, 35]. The release of these molecules leads to development of the characteristics of
inflammation, such as increased fluid retention at the site of infection, promotion of bloodclotting, proliferation of host cells, and neutrophil influx from the bloodstream to tissue [36, 37].
An influencing factor of SA pathogenicity is its ability to invade host cells as a
subversion tactic to avoid phagocytosis [36]. Once SA has gained endosomal entry into the host
cell, it can take several paths, dependent upon toxin or enzymatic gene presence and may be
phagosomally destroyed, proliferate within endosomes or in the cytoplasm following escape, or
5

induce intrinsic or extrinsic apoptosis [24].

A cytoplasmic PRR, nucleotide-binding

oligomerization domain-containing protein 2 (NOD2) is stimulated by a peptidoglycan
monomer; muramyl dipeptide (MDP) to further activate NF-κB mediated transcription of
cytokine and chemokines to promote neutrophil diapedesis from the bloodstream [38].
Extracellular and intracellular PRRs play a crucial role in the innate immune response, further
demonstrated in TLR-2 and NOD2 gene knock-out mice, which cleared less SA and developed
more serious skin lesions when compared to wild-type after subcutaneous injection with SA [39].
When stimulated with staphylococcal proteins, antimicrobial ability of nasal secretions
varies among individuals from differences in regulation of gene expression of AMPs and proinflammatory proteins due to host genetics or environmental factors, however persistent human
carriers generally have been found to have low antimicrobicidal activity in nasal fluid compared
with non-carriers [21, 29, 40]. There are documented associations of polymorphisms in innate
immune genes, defensins for example, resulting in a lowered constitutive threshold of wellfunctioning AMPs in the nasal epithelia, leaving them susceptible to various infections [29],
including opportunistic SA strains. The immunocompromised are at especially high risk of
infection, and with roughly a third of the human population asymptomatically colonized; there
exists high risk of dissemination in healthcare facilities and within communities [41].

Microbiome Interference has an Antagonistic Effect on Staphylococcus aureus Colonization
Human host pro-inflammatory responses and SA genetics are not the only factors in the
establishment of SA colonization, but the variety and abundance of non-SA microbiota has also
been demonstrated to prevent or remove SA from the nares and is at least partially influenced by
sex and host genetics [42]. The human nasal microbiome is under-explored, mainly due to low
6

comparative microbial population and few serious disease states associated with the upper
respiratory system, while the majority of microbiome analyses have been focused on the gut due
to serious illnesses such as Crohn’s disease [43]. Limitations of microbial culturability and
subsequent error in determining species-level identification of a total sample have proven
difficult as nutrient-poor nasal passages contain folds less microbes as compared to the nutrientrich gut.
There are many significant relationships that have been identified between SA and other
nasal commensal species that have been determined to be an additional factor of carriage outside
of the host immune response [44, 45]. Biological and niche interferences between SA and other
coagulase-negative staphylococci, Streptococcus pneumoniae, and members of phylum
Actinobacteria (Corynebacterium, Propionibacterium), have been analyzed and determined to
have a role in SA carriage duration, however the complexities of the relationships have been
limited by microbacterial culture techniques [44]. Interaction with Corynebacterium species in
particular have been observed to cause a shift toward commensalism through inhibition of the
accessory gene regulator (agr) system which is responsible for regulating quorum sensing, thus
decreasing translation of virulence factors associated with that system [45]. Another common
nasal inhabitant, Staphylococcus lugdunensis, is associated with inhibition of SA colonization
through production of a novel antibiotic that has been commercialized since to decolonize SA
and a wide range of other gram-positive microbes [46]. Diversity of species in the nares is also
correlated with decreased ability for SA to establish persistent nasal carriage. Hospital patients
persistently colonized with MRSA have been found to generally have less diversity of species in
the nares than non-colonized controls, but the presence of Streptococcus and Lactobacillus
species were found to have a protective effect [47], with Streptococcus also reported to compete
7

with SA in neonatal units [47, 48]. This shift observed in SA from a pathogenic to a commensal
phenotype may be explained by interference from other nasal commensals and would be
important to further characterize in humans to understand the dynamics of nasal carriage and
clearance in persistent, intermittent, and non-carriers. The pigtailed macaque nasal microbiome
has not been characterized thus far, however benefit would be had in making comparisons in
determining its use as a human-relevant model and in uncovering any relationships between SA
and inhibitors that could lead to future development of novel antibiotics.

Rodent Models of Staphylococcus aureus Nasal Carriage Translate Poorly to the Human
Condition
Historically, rodents have been extensively utilized in cancer, HIV, microbial, and many
other areas if study because they are relatively economical, easily and inexpensively maintained,
docile in handling, and can be genetically modified in ways to fit the study in question, allowing
researchers great insight to mammalian biological mechanisms. Mice have been implemented in
experimental models for SA induced cutaneous infections, sepsis, endocarditis, and others and
have identified key SA virulence factors and mechanisms of adhesion [49]. These studies have
greatly added to the scientific knowledge of SA, however failures in progression of therapies
from rodents into human trials have led to the question as to whether mice are acceptable models
for human responses to SA infection [49].
The nasal anatomical and histological differences between mice and humans are
significant, since mice are obligate nose breathers [50]. The nares contain the same epithelial
cell types, transitioning from stratified squamous in the anterior to pseudostratified columnar in
the posterior, but in dissimilar ratios and with a five-fold increase in complex turbinate surface
area in mice [51]. Rodents live with their faces about an inch off the ground, and the primary
8

function of the murine nasal passage is olfaction, which is reflected in the differences in anatomy
and cell-type striations as compared to humans where the function of the nasal passage is
respiration [50, 52]. They are quadrupedal, and humans and non-human primates are mostly
bipedal, therefore the head and nasal cavities evolved differently to reflect this, and rodents have
a more pronounced backward tilt to the head that likely affects rate of sinus drainage. Another
important factor, rodent nasal openings are devoid of hair follicles, a major niche occupied by
SA and its competitors in the human nose, likely a main reason that SA is not naturally supported
[22, 50]. When using mice for intranasal SA studies, longitudinal studies are impossible as their
noses are too small to be swabbed. Monitoring for SA carriage leads to sacrifice of subjects at
varying time points and surgical removal of noses for excision of nasal tissue and quantification
of total nasal flora by plate counts [50, 52]. These aspects are less than ideal for tracking SA
carriage rate and correlating individual innate responses with bacterial load over time as can be
done with human studies.
Another undesirable aspect of utilizing mice as SANC models is that their host defense is
dissimilar to humans in pronounced ways, therefore, rodents respond to the presence of SA
differently and are resistant to nasal colonization [53]. In the human innate response, host nasal
epithelial cells sense SA cell wall constituents and rapidly release chemokines to attract
neutrophils to the site of infection [54].

Once neutrophils arrive and mature, they clear

extracellular bacteria through release of oxidative bursts and phagosomal destruction of cells by
the release of defensins, an important mechanism that is absent in mouse neutrophils [54].
Human blood contains approximately 70% circulating neutrophils, while mouse blood is more
leukocyte-laden, with only about 20% neutrophils [52]. The innate response to nasal SA in
rodents is primarily T helper cell mediated, with a corresponding up-regulation of IL-17 [55].
9

Further discrepancies include variances in B- and T-cell signaling pathways, cytokines and their
receptors, expression of co-stimulatory molecules, PRRs, balance of leukocyte subsets, among
many other inconsistencies [52].
Previous research has shown that most animals, including mice, implemented in studying
SA pathogenesis are not natural nasal carriers of SA, a feature beneficial in mimicking human
nasal carriage [56]. This contributes to establishing only transient SANC in the majority of study
subjects for only a span of a few days, even when up to a billion SA CFUs are inoculated into
each nostril and streptomycin antibiotic is provided in drinking water to reduce non-SA
competition in the nose [1, 50, 57]. Human carriers readily support SA nasal inoculations over
periods of weeks and months with no outside intervention to force nasal carriage [28, 58]. A
new model is needed that also readily supports human physiologically relevant inoculations of
SA without enormous inoculums and antibiotic knockdown of the non-SA commensal
microbiome, as this is not true to the human condition.
The cotton rat (Sigmodon hispidus) model has been used for identifying bacterial
determinants of SANC [10, 59], as its anatomy and histological striations are more comparable
to human nasal passages than typical mouse models [60], however, in terms of the nasal
microbiome, very different bacterial profiles are supported and longitudinal studies are still
impossible in this model due to its small size. As discussed previously, the human nasal
microbiome is dominated by Staphylococcal species and can be highly variable, while
implementation of next-generation sequencing (NGS) showed that the cotton rat nasal
microbiome is comprised of roughly half Campylobacter species, and the rest are potential
gastrointestinal and oral pathogens, all not found in human noses [61]. These differences in
supported species are likely due to the absence of hair follicles in the nostrils of the cotton rat,
10

which is an important ecological niche occupied by SA and its competitors in the human nose.
The interactions between SA and the rodent nasal microbiome must therefore be dissimilar to
those in the human nose and compounded with the immune response differences already
discussed presents additional motivation for an improved model for human SANC.
Regardless of these points, implementation of rodent models for SANC studies is not
ideal for a simple fact that longitudinal correlations between the presence or absence of SA with
immune factors is impossible because rodent noses are too small to be swabbed, leading to the
sacrifice of several animals every few days. Measuring the individual rodent’s response to SA
inoculation is impossible and knowing that the human response to SA is very personalized, a
human-relevant model is needed that can be easily monitored over a long period of time to make
similar distinctions as we can in humans to determine the mechanisms explaining why healthy
people asymptomatically carry SA while others seemingly do not.

The Pigtailed Macaque (Macaca nemestrina) as a Potential Human-Relevant Model of SANC
Ideally, research on human SANC would be performed in the most accurate model, the
human, however, in the US, there are strict ethical and procedural limitations to human
experimentation. SANC is largely asymptomatic, so there is little pressure in recruitment of
subjects from clinical settings since most nasal carriers are unaware that they are carrying, and
retention of subjects is not always maintained due to the absence of symptoms and the presence
of human free-will. For participation in SANC studies, subjects are required to apply antibiotic
to their own nostrils to clear SA and complete the full regimen, and it is difficult to ensure
completion, which can lead to skewed results. A study cannot inoculate human subjects with
potentially virulent or antibiotic resistant strains, in fact, the only SA strains acceptable for
11

human nasal inoculations are isolates from each subject’s own nostril, and must be self-applied
[28, 58]. This prevents the increase in knowledge of colonization mechanisms and the immune
response to virulent strains, which would be beneficial in understanding progression of SA
disease states.

Human study subjects are typically required to longitudinally return to the

laboratory for nasal swabs, nasal fluid collections, etc. and the free-will factor can cause
procedural limitations when subjects fail to return.

Removing the free-will element and

eliminating as many factors as possible (environmental changes, diet, stress, illnesses) that have
been seen in humans to impact SANC in creation of a reliable model that will be present for all
follow-up visits will be useful in circumventing the ethical and procedural limitations in human
research.
The pigtailed macaque (Macaca nemestrina) is a medium-sized monkey found in
Indonesia, Malaysia, and southern Thailand, with a captive life-span of 27-35 years [62].
Females and males have very different temperaments; females are typically docile unless
threatened and can be trained to easily cooperate in certain treatments or interactions, while
males are aggressive and are maintained for breeding purposed in a research setting [63]. Sexual
maturity for females is about 3 years of age, and their yearly hormone fluctuations and 28-day
menstrual cycle resemble the human female condition, including the ability to breed year-round
(unlike other monkey models) [64]. Hormonal fluctuations have been shown to influence the
human female immune response [65]; therefore to use an animal model with very different
hormonal cycles (such as rodents) is erroneous in translation to the human condition.
Collaborators of this study at the Washington National Primate Research Center (Seattle, WA.)
primarily house the pigtailed macaque due to their similarities to humans, and have implemented
this model for years in research centered on reproductive and rectal mucosa and potential
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microbicides to treat or prevent sexually transmitted infections (STIs) like HIV and chlamydia
[64-66].

Similarities in mechanisms and acquisition of human-relevant STI’s, clinical

presentation of infection, innate responses and microbiome in the reproductive mucosa, fetal
development of the respiratory system, and more have been determined through increasing use of
this model over the past 10 years [67-71].
There are many similarities between human and rodent systems, but it cannot be assumed
that what is true in murine immunology is true in the human, as these differences lead to billions
of dollars in wasted funding in failed clinical trials every year, driving up the cost of drug
development.

Rodent models have uncovered many SA adhesion and virulence factor

mechanisms that were once a mystery, however colonization and clearance mechanisms of
SANC are still not understood due to the differences in systems. Why do so many healthy
humans persistently carry millions of SA cells in the nose without symptoms, while others do not
seem to ever carry or only intermittently? Nasal carriers are not suffering from a neutrophilic
disorder and have just as many circulating in the blood as non-carriers. The lack of a humanrelevant model has essentially brought SANC studies to a stand-still, and development of a
model in which many subjects can be easily and simultaneously decolonized and recolonized
with a variety of SA strains would circumvent limitations in murine and human experimentation.
The cost of non-human primate research is considerably higher than murine studies, however,
further development of an improved model may yield results with improved translation to the
human condition, prevent the loss of funds in the transition from pre-clinical to clinical human
trials for new therapies, and balance out the cost of maintaining the model.
This study implements the pigtailed macaque (Macaca nemestrina) in a series of
independent decolonization and recolonization SA inoculation experiments with a variety of SA
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strains, including one human isolate. Development of this potential model for human SANC
includes: observation of nasal and extranasal acquisition and carriage patterns following safe and
appropriate nasal inoculations, innate responses to SA presence in the nasal mucosa, and
comparisons between components of human and pigtailed macaque nasal microbiomes.
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CHAPTER 2: LONGITUDINAL ASSESSMENT OF STAPHYLOCOCCUS
AUREUS NASAL CARRIAGE DYNAMICS IN A HEALTHY COHORT OF
PIGTAILED MACAQUES
Introduction
Staphylococcus aureus is a transient part of the normal flora of human skin, but
preferentially occupies the moist nasal vestibule of approximately 30% on a world-wide scale.
Longitudinal human studies have elucidated three accepted categories of nasal carriage:
persistent (always SA-positive), intermittent (periodically clears SA from the nares), and noncarriers (always SA-negative by standard culture methods). Human SANC studies have also
elucidated that nasal colonization is not solely reliant upon the bacterial strain but is also
impacted by a myriad of other factors, such as host genetics, the speed and effectiveness of
immune responses, and environmental factors. A study from the Netherlands, where fewer
procedural limitations exist, discovered that intermittent and non-carriers share similar antistaphylococcal antibody profiles, and that persistent carriers tend to preferentially select their
autologous, or self-isolated strain from a mixed inoculum [2]. Procedural and ethical limitations
in the US prevent human studies of this type since only autologous strains are allowed for
inoculation studies, however following development of a human-relevant model this and other
limitations could potentially be circumvented. The pigtailed macaque has been well-established
as a suitable model for the female reproductive system and has many advantages over using
common rodent and other small animal models. The tissue structure and immune responses in
the reproductive mucosa of pigtailed macaques has proven similar to that of human females and
support similar vaginal flora, and both have similar 28- to 30-day menstrual cycles and hormonal
fluctuations [66, 72]. Implementation of the pigtailed macaque reproductive model has been
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useful in studying sexually transmitted infections like HIV, trichomoniasis, and chlamydia [64,
72], and several potential microbicide trials have resulted [66, 73].
An effective model for SANC would require the possibility for many subjects to be
simultaneously decolonized of SA and recolonized again with a variety of strains to
longitudinally follow carriage patterns and immune responses. This study over the course of 18months validated six female pigtailed macaques as natural SA carriers, then follows their
carriage patterns and their innate immune response to SA presence through a series of various
autologous and non-autologous strain inoculations, one of which was a human nasal SA isolate.

Materials and Methods
Study Participants and Ethics.
This study was performed with pigtailed macaques (Macaca nemestrina) housed at the
Washington National Primate Research Center (WaNPRC), in accordance with all institutional
and federal guidelines for the care and use of laboratory animals. Housing and care conditions at
the WaNPRC facilities meet AAALAC accreditation standards for non-human primates and
follow NIH guidelines for ABSL-2 containment facilities. Ambient temperature in the animal
rooms was between 22.2° to 25.6° C with relative humidity between 30-50%, and maintained on
12 hour light and dark cycles [74]. The study-specific protocol was reviewed and approved by
the Institutional Animal Care and Use Committee of the University of Washington. On days
where mupirocin ointment was applied only, animals received a light dose of 0.8-mg/kg
ketamine, with antibiotic applied while still in their cages. For screening and sample collections
(nasal and extranasal swabs, nasal fluid collection, and blood draws), animals were sedated with
1.2-mg/kg ketamine and moved from their cages to a procedure room. Six healthy, sexually
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mature female pigtailed macaques were selected from a colony of 17 healthy individuals whose
nasal and pharyngeal SA carriage status was monitored for two months. Subjects were chosen
based on ability to naturally acquire and carry SA at mid-high SA loads in the nasopharynx as
well as availability for participation in the study for the approximate 18-month duration. There
were no clinical adverse effects of nasal SA inoculation reported during the duration of the study.
The study subjects were monitored for changes in temperature and body weight at each weekly
sedation, with no changes in behavior or diet noted. Previous human nasal carriage studies
performed by the Cole Laboratory that are referenced were previously described [58, 75] and
were performed under guidelines of the Institutional Review Board of the University of Central
Florida.

Animal Screening for SA Carriage and Sample Processing
To screen pigtailed macaques for SA carriage, the nostrils and pharynx were sampled
using flocked Copan Diagnostics Eswab mini-tips and stored immediately in 1 ml of Eswab
(liquid Amies) medium in transport tubes (Fisher Scientific #23600901). Samples were shipped
overnight on ice packs to the Cole Laboratory and processed immediately upon arrival.
Transport tubes were vortexed, and swabs were streaked onto BBL CHROMagar plates for
colorimetric rapid validation of SA presence. Swab tips from each sample were reserved in a
labeled cryotube and stored at -80°C for any further downstream use. Eswab media was diluted
into Hank’s Balanced Salt Solution (HBSS) at 1:10, 1:100, and an additional 1:1000 for pharynx
and vaginal samples. These dilutions along with a straight (undiluted) sample were plated on
Tryptic Soy Agar with 5% sheep’s blood (TSA II, Fisher Scientific cat# B21261X) to quantify
SA and non-SA colony-forming units (CFUs).
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Leftover Eswab sample was stored as

representative “early” glycerol stocks (500 μL sample + 500 μL 70% TSB/30% glycerol) at 80°C, and any leftover swab liquid (~100 μL) was cultured overnight (18 hrs/37°C/250rpm) in 2
mL TSB and stored at -80°C as a “late” glycerol stock (500 μL sample + 500 μL 70% TSB/30%
glycerol). SA colonies were identified as phenotypic β-hemolytic colonies on TSA II and
confirmed with Staphyloslide Latex Agglutination Test (Fisher Scientific cat# B4340953), which
identifies presence of SA-specific protein A. Then the colony was plucked with a sterile pipette
tip for overnight subculturing in TSB to reserve SA colony glycerol stocks for any future use.
Following subject selection, this identical protocol was followed for all sample sites (left and
right nostrils, pharynx, left and right axillae, left and right palms, and vagina) each week for ~18months.

MLST and Spa Typing of SA Isolates
The nasal SA strains isolated from these animals were characterized using multilocus
sequence typing (MLST), which exploits conserved genes that encode essential housekeeping
enzymes within a species [76]. These are amplified with PCR, followed by analysis of the
resulting DNA sequences of the MLST loci, then are assigned allele numbers, the combination of
which identify the strain as a strain type (ST). USA300-0114 (NRS384) was obtained through
the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) program,
supported under NIAID, NIH Contract No. HHSN272200700055C and used as a positive control
for PCR reactions. Human nasal isolates were collected as described previously [28], and
processed identically to pigtailed macaque isolates described herein. SA colonies from each
animal’s nostril were plucked from TSA II plates used to enumerate SA and non-SA, and
subcultured overnight in 5 mL TSB (18 hrs/37°C/250rpm). Genomic DNA was extracted from
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these isolates using UltraClean Microbial DNA Isolation Kit (MO Bio Laboratories, West
Carlsbad, California, USA) according to manufacturer's instructions, except instead of using 1.8
mL of sample, 800 μL were extracted unless bacterial pellet was insufficient. Resulting genomic
DNA was placed in seven separate PCR conditions with the appropriate primers (Table 1) to
amplify the seven MLST genes (arcC, aroE, glpF, gmk, pta, tpi, and yqiL) in adherence with the
described protocol [77] with the remaining DNA numerically coded and reserved at -20° C until
further use. PCR amplicon sizes were verified with negative (no DNA) and positive (USA300
amplicons) by gel electrophoresis, then sent to Eton Biosciences (Research Triangle Park, NC)
for Sanger sequencing using the same primers as used in PCR. Mega7 was used to form a
contiguous sequence using forward and reverse sequences. The Staphylococcus aureus MLST
database (http://pubmlst.org/saureus/) was utilized to assign allele numbers and identify
sequence types (STs) for each of the seven alleles and SA isolates respectively. SA genomic
DNA was used in a similar manner for staphylococcal A protein (spa) typing according to
previously described procedures [78]. Spa types were determined using Ridom StaphType
software (http://www.spaserver.ridom.de/) after receiving spa sequence data from Eton
Biosciences. Newly identified sequence types were synchronized with the RIDOM server, and
were used throughout the study to validate nasal and extranasal SA detections as identical to the
inoculated strain.

Comparative Genetic Analyses of Macaque and Human Nasal Isolates
Eight SA strains isolated from previous human study donors [75] were genetically
compared to the three SA strains isolated from the six pigtailed macaques in this study. Multilocus sequence typing (MLST) was performed initially for seven housekeeping genes (arc, aroE,
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glpF, gmk, pta, tpi, and yqil) to characterize the isolates, and numerical identifications were
obtained from the Staphylococcus aureus MLST database (http://pubmlst.org/saureus/). The
seven MLST allele sequences were concatenated for the eight human and three macaque SA
strains, aligned with each other, and analyzed using MrBayes v3.2 Bayesian analyses to form a
phylogeny to view evolutionary relationships. Human SA isolate from donor (D) 579, which
was previously identified as ST398 was found similar to macaque strains ST3814 and ST3815
while other human isolates were further diverged.

Verification of Methicillin-Susceptibility of Implemented SA Strains
It was important to ensure that the SA strains chosen for nasal inoculation studies in the
chosen cohort of healthy pigtailed macaques were not methicillin resistant, as we wanted to
avoid infecting the animals with difficult to eradicate virulent strains. The mecA gene encodes
the penicillin binding protein, PBP2A, which is responsible for disrupting the lactam ring in
several antibiotics and is present in methicillin resistant strains of SA.

For validation of

methicillin susceptibility, the PCR amplification of mecA was performed for each human and
pigtailed macaque SA isolate using MR1 and MR2 primers (Table 1) under PCR conditions
adopted from a previous study [79]. The absence of a corresponding 1.3 Kb band after gel
electrophoresis was indicative of the lack of the mecA gene (as compared to USA300 MRSA
strain as a positive control).

These were further validated as mecA negative by plating

corresponding bacterial samples on MRSASelect chromogenic agar plates (Bio-Rad, Hercules,
CA, USA) according to manufacturer’s instructions. When plated, the USA300 MRSA strain
control presented as pink colonies, indicative of methicillin resistance, while all other susceptible
strains grew as white colonies.
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Verification of Mupirocin Susceptibility of Implemented SA Strains
Macaque strain types 3813, 3814, 3815 and human strain D579/ST398 were verified
susceptible to mupirocin antibiotic application through multiple liquid turbidity (growth) assays
[80]. Snap frozen cultures were thawed on ice, vortexed vigorously, and 50 μL was proliferated
in 5 mL TSB in a shaking incubator (2.5 hrs/37°C/250rpm) to log phase growth. Optical density
(OD) of a 1-mL sample of each was measured at 550 nm to achieve a desired absorbance reading
of 0.8, indicative of approximately 108 SA CFU/mL. Depending upon the OD measurement,
approximately 100μL of each log phase SA culture was serially diluted in pre-warmed (37° C)
Mueller-Hinton broth (MHB) (BD, cat# 275730) with 5% sucrose to achieve approximately 104
CFU in 90μL SA/well of a 96-well clear-bottom plate (TPP/ Midsci, cat# TP92096). Input
CFUs were also verified through back calculating two serial dilutions of each strain on TSA II
agar plates.

A 1-mg/mL mupirocin (Sigma-Aldrich, cat# M7694) stock was prepared in

dimethyl sulfoxide (DMSO), then diluted in HBSS to 80, 40, 20, and 10 μg/mL. These working
solutions were diluted 1:10 in SA on a 96-well plate to achieve 1, 2, 4, and 8 μg/mL final
concentrations of mupirocin. Controls for the assay included an aminoglycoside antibiotic,
tobramycin, a known SA inhibitor; an antibiotic-free growth control with DMSO to ensure that
the vehicle was not inhibitory to bacterial growth; and a negative control of MHB/5% sucrose to
ensure sterile media.

Once loaded, the plate was sealed with ThermoSeal A Film (Excel

Scientific, Inc., cat# TSA-100) and placed into a pre-warmed (37°C) SpectraMax 190 microplate
reader (Molecular Devices, Sunnyvale, CA). Over the course of the 16-hour kinetic assay,
turbidity as indication of bacterial growth at OD 550nm was measured every five minutes
following brief 15-second agitations. OD 550nm measurements for all wells were exported and
resulting growth curves were plotted against time (hourly time points) using GraphPad Prism 7
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software. Following the 16-hour assay, 10 μL of each strain per treatment was plated on TSA II
agar and β-hemolytic colonies were enumerated the next day following incubation. Each strain
proliferated to approximately 108 CFU/90μL in antibiotic-free wells as back calculating CFU
counts from serial dilutions on TSA II plates, and each strain was susceptible to mupirocin
concentrations as low as 1 μg/mL.

Experimental Nasal SA Inoculation of Pigtailed Macaques.
Prior to experimental inoculations, the pigtailed macaques were decolonized of
endogenous SA by the application of a pea-sized amount of 2% topical mupirocin ointment
(Bactroban, GlaxoSmithKline, Philadelphia, PA) to each nostril followed by a brief massage of
the exterior nostrils. This was performed under light anesthesia while remaining in their cage
twice a day for five days to clear the body of SA. Following the fifth day of mupirocin
application, the nasal microbiome was allowed to normalize over a four-week period prior to
experimental SA inoculations. During this recovery period, the nostrils, pharynx, axillae, palms,
and vagina were monitored for SA and to enumerate non-SA as an indication that the commensal
population had replenished by inoculation day. During the fourth week of post-mupirocin
commensal normalization, experimental strains were prepared and enumerated for inoculation as
follows: SA colonies were proliferated in 50mL TSB (18 hrs/37°C/250rpm), after which 1-mL
was subcultured in 50 mL TSB (2 hrs/37°C/250rpm). Liquid culture was added to a conical
tube, centrifuged five minutes at 3000 xg, after which supernatant was removed and the bacterial
pellet reserved. Pellets were resuspended in 35mL HBSS with 1% bovine serum albumin (BSA),
spun down again, and the pellet resuspended in another 35mL HBSS/1% BSA. This suspension
was well-mixed, transferred to 1.5mL microtubes and snap-frozen in liquid nitrogen for 3 hours,
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then kept at -80°C until future application. The concentration of each SA strain (CFU/mL) was
verified through dilution plating five aliquots of each snap culture on TSA II agar, enumerating
SA colonies, and back calculating to determine the average original concentration of each strain.
These back counts were used to design a dilution scheme per strain for the WaNPRC to deliver
103 or 104 CFUs in an inoculation of 20µL per nostril.

Under ketamine anesthesia, a

micropipette was used to administer the inoculum to both nostrils of the subjects, and the exterior
of the nostrils were massaged for 30 seconds to distribute throughout the nasal passage. The first
experimental inoculation implemented each individual pigtailed macaque’s SA strain to
determine an appropriate inoculum to successfully establish nasal and extranasal colonization
with the least CFUs as possible in 20µL, beginning with 103 CFU/nostril. This inoculum was
not successful in establishing carriage in most nostrils and extranasal sites as indicated through
dilution plating methods, therefore two weeks following the first inoculation, a second
inoculation was performed with 104 CFU SA in 20µL per nostril. This inoculum was successful
in establishing carriage through day 70 post-inoculation, therefore 104 CFU per nostril was
continued throughout the remaining three experimental inoculations of ST3813, ST3814, and
human isolate ST398 applied to all subjects, with nasal carriage established in each inoculation
for 63, 93, and 22 days respectively. Throughout each of the nasal microbiome normalization
periods and four experimental SA inoculation studies, nasal and extranasal swabs, nasal fluids,
and blood were collected at days 0 and 3 post-inoculation, then weekly until the end of followup.
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Statistical Analyses
All screening, turbidity assays, and carriage data were analyzed using GraphPad Prism 7
software (GraphPad Software, La Jolla, CA). Analyses of natural SA levels by body site (Fig.
3B) were log-transformed and compared using one-way ANOVA with Tukey’s multiple
comparisons test. Recovery of the non-SA nasal commensal population (Fig. 4) was determined
by averaging the nostrils per individual, log-transforming them, and comparing the weekly
results using paired t-tests. Autologous and non-autologous positive nostril SA CFU counts
(Fig. 7A) were found not significantly different through unpaired t-test (two-tailed). Survival
curves comparing autologous and non-autologous macaque inoculations (Fig. 7B) were found
not significantly different using both the Log-rank (Mantel-Cox) test and the Gehan-BreslowWilcoxon test. Human and pigtailed macaque nasal SA isolates were genetically compared (Fig.
8) using Mr. Bayes v3.2 phylogenetic analyses.

Results
Pigtailed Macaques (Macaca nemestrina) are Natural Carriers of S. aureus (SA) Strains at
Bacterial Loads Within Human Carriage Range
As previously mentioned, rodents are not natural carriers of SA in the nostrils and this
presents issues in maintaining carrier status even when inoculated with a billion SA CFUs or
more per nostril [1, 57, 59]. A natural nasal carrier of SA would be ideal for colonization
studies; therefore, 17 pigtailed macaques were assessed for nasopharyngeal SA carriage by a
two-month screening process. Each subject was swabbed in the nasal vestibule of both nostrils
and the pharynx at two screening visits eight weeks apart. Thirteen animals were colonized in
one or both nostrils at both visits, with all seventeen presenting positive for SA in either the nose
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and/or pharynx in at least one screening (Fig. 1). Six healthy females of reproductive maturity
were assigned to participate in a series of independent SA inoculation studies (red-boxed
identifications in Fig. 1) based upon mid-to-high SA CFU carriage and availability to participate.

Figure 1: Pigtailed Macaques are Natural Carriers of SA in the Nose and Throat.
Seventeen pigtailed macaques at the WaNPRC were screened for SA in the nostrils and the
pharynx twice, eight weeks apart and swabs were plated on TSA II to quantify SA. Boxed
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animal identification codes (Animal ID) indicate the six animals chosen to participate in a series
of inoculation studies. Error bars indicate mean±SD, the x-axis begins at the limit of SA
detection as plated on TSA II (10 SA CFU/swab).
Once subjects were assigned to this study, animals were maintained in separate enclosures, and
collected nasal isolates were genotyped by spa typing and multi-locus sequence typing (MLST)
implementing primers described in Table 1. Characterization of the macaque strain genotypes
was not only for the benefit of comparing the genetics to each other and to prior human SA
isolates, but to also provide a method to longitudinally validate that any SA colonies detected
nasally and at extranasal sites over the course of each individual experimental inoculation were
genetically indistinct from the SA strain placed into the nostrils.
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Table 1: Primers Implemented in this Study
Primers:
SA MLST:

spa typing:
MecA (-/+):
16S:

Primer Name
arcC
aroE
gLpF
gmk
pta
tpi
yqiL
1095F-1517R
MR1/MR2 (F/R)
27F-1492R
341F-785R

abbr
A
B
C
D
E
F
G
spa
mecA

Forward (5' - 3')
Reverse (5' - 3')
TTGATTCACCAGCGCGTATTGTC
AGGTATCTGCTTCAATCAGCG
ATCGGAAATCCTATTTCACATTC GGTGTTGTATTAATAACGATATC
CTAGGAACTGCAATCTTAATCC TGGTAAAATCGCATGTCCAATTC
ATCGTTTTATCGGGACCATC
TCATTAACTACAACGTAATCGTA
GTTAAAATCGTATTACCTGAAGG GACCCTTTTGTTGAAAAGCTTAA
TCGTTCATTCTGAACGTCGTGAA TTTGCACCTTCTAACAATTGTAC
CAGCATACAGGACACCTATTGGC CGTTGAGGAATCGATACTGGAAC
AGACGATCCTTCGGTGAGC
GCTTTTGCAATGTCATTTACTG
TAGAAATGACTGAACGTCCG
TTGCGATCAAATGTTACCGTAG
AGAGTTTGATCMTGGCTCAG
GGTTACCTTGTTACGACTT
CCTACGGGNGGCWGCAG
GACTACHVGGGTATCTAATCC
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Sequence analyses showed that animals A10023, K05139, T04293, and Z08064 carried an
indistinguishable sequence type (ST) 3813; A11236 carried ST3814; and Z08202 carried
ST3815, each characterized as new SA strains (Table 2).

Table 2: Human and Macaque Staphylococcus aureus Isolate Characterizations

SA Strain ID
ST3813
ST3814
ST3815
*USA300
D528
D547
D20
D579
D502
D812
D566

Origin
Pigtailed macaque
Pigtailed macaque
Pigtailed macaque
Human wound
Human nose
Human nose
Human nose
Human nose
Human nose
Human nose
Human nose

MLST
3813
3814
3815
8
8
5
30
398
105
716
30

SpA Type
t15866
t15867
t15868
t008
t008
t688
t12255
t571
t056
t008
t037

mecA (+/-) mupR (+/-)
+
-

SA: Staphylococcus aureus; MLST: multi-locus sequence type; SpA Type: Staphylococcal
protein A gene Ridom type; mecA: mecA gene presence (+) or absence (-); mupR: mupirocin
resistance presence (+) or absence (-). *USA300 strain isolated from wound, acquired from
NARSA program.
*USA300-0114 (NRS384) was obtained through the Network on
Antimicrobial Resistance in Staphylococcus aureus (NARSA) program: supported under NIAID,
NIH contract No. HHSN272200700055D.

SA Strains Implemented in this Study are Mupirocin-susceptible
Each strain isolated from the pigtailed macaques lacked the mecA gene encoding
methicillin resistance; however, it was desired to implement a topical antibiotic other than
methicillin to prevent the rapid acquisition of methicillin resistance in the pigtailed macaque
colony once the study ended.

All three macaque SA isolates and the single human SA

implemented in this study were validated as mupirocin sensitive with liquid turbidity assays prior
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to use in the animals. This study implements 2% mupirocin antibiotic ointment, applied twice-aday for five days to each nostril of the pigtailed macaques, which is the same concentration and
protocol used to eradicate nasal SA prior to surgery and clear skin infections in humans. Upon
challenging 104 CFUs of each strain with a low-level range of mupirocin concentrations, from 18 μg/mL, SA was inhibited with as low as 1 μg/mL as compared to the antibiotic-free growth
curve (Fig. 2A). Each curve is the result of averaging hourly OD (550 nm) measurements (as
indication of growth) of the three macaque SA isolates and the one human strain over the course
of the 18-hour assay. For each strain per treatment, 10 μL from post-assay wells were plated on
TSA II/5% sheep’s blood and any resulting SA colonies were enumerated and compared to input
and antibiotic-free SA CFU counts (Fig. 2B). Antibiotic-free/DMSO (vehicle) treatments of all
four SA isolates proliferated to 108 CFUs from an approximate input of 104 CFUs (error bars
indicate mean±SEM). Mupirocin concentrations of 1-8 μg/mL were inhibitory for all strains;
post-assay SA colony growth from the 8 μg/mL treatments occurred only twice and only with
macaque isolates ST3814. Post-assay growth for the 1 μg/mL occurred often and with all tested
strains, suggesting that these low concentrations used in turbidity assays are bacteriostatic rather
than bactericidal. In vivo application of mupirocin ointment delivers concentrations estimated
between 5000-10,000 μg in a pea-sized amount (estimated as a fourth to a half of a gram) of 2%
mupirocin ointment, twice-a-day, for five days and not only in one application as in the in vitro
turbidity assay.
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Figure 2: Nasal SA Isolates Implemented in Experimental Inoculations were Susceptible to
Mupirocin Application
A) Liquid turbidity assays with low-level range of mupirocin concentrations (1-8 µg/mL) were
applied to four SA isolates (three macaque, one human). Growth curves (OD plotted against
time) were generated for each treatment versus an antibiotic-free growth curve (blue) for
comparison. B) One well per each strain was plated on TSA II per treatment (including
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antibiotic-free) following the 16-hour assay. Resulting SA colonies were counted and compared
to input CFUs (indicated through pre-assay plate counts). n=15 (5 experiments, 3 replicates per
strain), error bars indicate mean ± SEM.

The Nasal Vestibule is the Primary Reservoir of SA in the Pigtailed Macaque
Screening SA CFU counts prior to any manipulation revealed that pigtailed macaques
naturally support SA in the nose and pharynx within range of human nasal carriers.

To

determine if the nose is also the reservoir for SA in the macaque, animals were swabbed in the
left and right nostrils, pharynx, left and right axillae, left and right palms, and vagina to
enumerate the comparative SA loads of these sites that are observed in humans to have increased
SA during heavy nasal carriage. Immediately following, application of 2% topical mupirocin
ointment to the nostrils was continued twice-a-day for five days, then these same sites were
followed for four weeks. Figure 3A shows the average SA load at eight swab sites at “PreMupirocin”, and Weeks 1-4 “Post-Mupirocin” for 6 macaques during four independent
experimental inoculations. Pre-mupirocin counts show that the nostrils contained significantly
higher SA loads compared to all other extranasal sites, and the pharynx contained the most SA
out of the six extranasal sites but less than the nostrils. Mupirocin ointment was only applied to
the nasal vestibule, but by week one post-mupirocin, all sites were cleared. Out of 24 total
weekly swabs per site over the post-mupirocin periods, ≥21 samples were negative for SA once
the nostrils were cleared.
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Figure 3: The Nasal Vestibule is the Predominant Reservoir of SA in the Pigtailed Macaque
A) The nostrils and each extranasal site were swabbed prior to antibiotic treatment, then weekly
after the five-day course of 2% mupirocin ointment applied to the nostrils only. The nostrils and
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rest of the body were effectively cleared of SA. Error bars indicate mean±SEM, n=24 (6 animals,
4 experiments). B) Detection of natural SA carriage (i.e. not due to experimental inoculation of
the nostrils) collected over an 18-month period shows elevated SA load in the nares (double
asterisk). Single asterisk indicates an elevated SA load when compared to extranasal swab sites.
n= 19-115 swabs depending on anatomical site. Error bars indicate mean±SEM.

To further demonstrate that the nostrils are the primary reservoir, natural SA levels of the
six extranasal sites were analyzed concurrently alongside the nostrils of the six animals: the
pharynx, left and right axillae, left and right palms, and the vagina. Figure 3B displays natural
SA positive swabs, excluding nasal SA CFU counts resulting directly from experimental
inoculations of SA.

Nostril swabs included in this figure are screening CFU counts, pre-

inoculation samplings, or when clearance of experimentally inoculated SA was observed for two
consecutive samplings before detection.

All SA positive swabs were included for the six

extranasal sites as these never received any experimental inoculations and naturally acquired SA
from the individual’s own nose. Natural SA carriage in the nostrils significantly outnumbered all
other extranasal sites for frequency of positive swabs as well as SA load as indicated by double
asterisks. Considering the extranasal sites only, the pharynx swabbed positive for SA at a higher
frequency with a higher density of SA, however again, lower in positive swab frequency and SA
load than the nostrils indicated by a single asterisk (Fig.3B). Taken together, these data suggest
that like human SANC, the primary reservoir of SA in the pigtailed macaque is the nasal
vestibule and is spread to extranasal sites through passive hand-face-body contact.

Nasal Non-SA Commensal Population Recovers Prior to Experimental Inoculation
To validate an animal model of SA nasal carriage, multiple animals need to be
simultaneously cleared of SA, nasally inoculated with strains of choice, and followed up together
easily. For each of the four individual experimental inoculations, all six subjects were cleared of
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nasal SA successfully with mupirocin antibiotic ointment and swabbed for four weeks to validate
SA clearance and monitor the non-SA commensal population using dilution plating on TSA II
agar. Other gram positive non-SA commensals are susceptible to mupirocin, so it was expected
that the non-SA CFU counts would decrease at least temporarily, but recovery should occur by
inoculation day so that SA can be introduced to as close to a normal environment as possible for
each individual. Figure 4 displays that the mupirocin regimen significantly decreases the nonSA nasal population as demonstrated by week one TSA II plate counts.

Figure 4: The Non-SA Nasal Commensal Population Recovers Prior to Experimental Nasal
Inoculations
Macaque nostrils were swabbed prior to the first nasal mupirocin application, then weekly for
four weeks afterwards, and the non-SA population was enumerated on TSA II blood agar plates.
Paired non-SA CFU enumerations show the commensal population is significantly decreased one
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week after mupirocin application (p=0.0481), however recovers by Week 3 Post-Mupirocin.
Experimental inoculations occurred following the Week 4 swab collection. Error bars indicate
mean±SEM, n=36 at each time point (6 animals, 2 nostrils each, 3 inoculation studies).

By Week 3 Post-Mupirocin, the nasal commensal population appeared to be fully restored, and
the animals remained SA negative except for one individual (data shown Fig 3A). Experimental
SA nasal inoculations took place immediately after the Week 4 Post-Mupirocin samples were
collected.

A Human-relevant Inoculum of Staphylococcus aureus Establishes Asymptomatic Nasal and
Extranasal Carriage in all Subjects
As this is the first study of this type, there is no prior knowledge on how much SA is
required to establish carriage with a nasal inoculum of SA in the pigtailed macaque. The first
inoculation was designed to identify the lowest nasal inoculum of SA to not only establish nasal
and extranasal carriage in most subjects within the first two weeks of follow-up, but also prevent
erroneously overloading the nasal mucosa and microbiome with SA. The first inoculation
experiment involved clearing the nares and re-introducing the strain of SA isolated from each
individual. Figure 5 is a heat map generated from log-transformed carriage data to give a quick
visual representation of relative SA density in the nose and extranasal sites over ten weeks of
follow-up. Green is indicative of an SA count at or below the limit of detection based on
dilution plating methods (LOD≤10), and ranges from yellow (low SA load, >10) to brick red
(highest SA load, ≥106). For paired sites (nostrils, axillae, palms), SA detections are averaged.
Six animals were first inoculated with 103 CFU/20 µL of their own individual isolate in each
mupirocin-cleared nostril (Inoc. 1), and followed at day 2, then for two weeks by swabbing the
nares and extranasal sites for detection of SA on TSA II agar. SA detection on day 2 post35

inoculation one showed that 5 of 6 subjects were positive for SA in at least one nostril, and few
extranasal sites. Day 7 post-inoculation one SA quantification indicated that 3 of 6 subjects had
cleared both nostrils, and only 6 of 36 extranasal sites were detectable for SA. After sample
collection on day 14, each subject received another nasal inoculation (Inoc. 2) of approximately
104 SA CFU in each nostril (same self-strain). Sample dilution plating of day 14 samples
revealed that 3 of 6 animals remained nasally colonized and only 5 of 36 extranasal sites were
still detectable for SA. Following the second inoculation, day 21 of follow-up showed that SA
established colonization in all nostrils, and then subjects were followed for an additional 8 weeks
of nasal and extranasal swabs, nasal fluid, and serum collections for a total of 70 days. Most
extranasal sites were eventually colonized during this time in subjects with high nasal SA loads,
importantly Z08064 and Z08202, both of which reached levels from 105-106 CFUs/swab and
tended to carry higher when positive for SA over the course of the study. One animal (T04293)
cleared the nostrils of SA by day 56 and remained clear until the last sample before mupirocin
clearance, important to note as this shows that the inoculum was adequate in establishing
carriage but was not so high to prevent clearance.

36

Figure 5: Long-term Nasal and Extranasal SA Carriage is Established with a Human-relevant Nasal Inoculation of 104 SA
CFUs/nostril
Animals were cleared with a regimen of mupirocin ointment and recolonized with their own SA isolate. After 4 weeks of
microbiome normalization, 103 SA CFUs were delivered to both nostrils. CFU counts as detected on TSA II plates are shown as
log-transformed, and paired sites are averaged and shaded according to SA load, legend on the right. By day 7, 3 of 6 subjects had
cleared both nostrils, and only 6 of 36 extranasal sites contained detectable SA. Immediately following day 14 swabs, all nostrils
received 104 CFUs of their own isolate again, which was sufficient in establishing carriage in all nostrils, and animals were
followed for another 8 weeks. Most extranasal sites were eventually detectable for SA, especially in animals that achieved high
SA load in the nose.
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Autologous and Non-autologous SA Strains Were Supported Similarly During Longitudinal
Pigtailed Macaque SANC
Once an appropriate inoculum was determined with each of the subjects’ own strains, two
cycles were performed of mupirocin clearance of the nostrils, a 4-week normalization period,
and inoculation of 104 SA CFUs into each of the pigtailed macaques’ nostrils. Carriage of
autologous versus acquisition of non-autologous SA strains has been implicated in influencing
duration of human nasal carriage and bacterial load [2]; therefore it was desired to determine if
the pigtailed macaques are similar. Two macaque SA isolates were implemented in separate
inoculation studies, ST3813 and ST3814, applied to all animals’ left and right nostrils, then
followed for 63 and 93 days respectively.

Inoculation of ST3813 to all six animals was

autologous (indistinguishable from original nasal strain) to four, and non-autologous to two
macaques. Inoculation of ST3814 was autologous to only one animal, non-autologous to the
other five. These were administered to each animal regardless of whether it was autologous or
not to the originally detected strain to determine if strains are carried differently if they were
originally residing in that individual’s nostril or completely new to the environment. Animals
were swabbed in the nostrils and at each extranasal site (pharynx, axillae, palms, vagina), nasal
fluids were collected, and blood drawn each week throughout. Nasal and extranasal SA and nonSA were enumerated weekly through dilution plating swab samples on TSA II plates. Each dot
on Figure 6A represents one animal’s log-transformed averaged nostril, separated by autologous
(left) or non-autologous (right) positive SA loads. There was a total of 5 autologous and 7 nonautologous inoculations, with most of the non-autologous inoculations occurring in the
independent study with the longer duration (93 versus 63 days). The supported SA load was not
significantly different between autologous and non-autologous groups as determined through a
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two-tailed unpaired t-test (p=0.1281). Importantly, the mean averaged nostril detection for both
autologous and non-autologous macaque strains was approximately 104 SA CFUs/ swab, while
the median SA load in human nasal carriage is 9.8 x 104 SA CFUs/swab [58]. Additionally,
there was no significant difference in duration of survival between autologous and nonautologous SA strains. Survival curves were generated using the same longitudinal CFU counts
from day 2 or 3 post-inoculations, then weekly over the duration of both inoculation studies (Fig.
6B). All nostrils received identical treatments; therefore, detectable SA in at least one nostril
was considered survival in that animal.

Autologous and non-autologous SA strains both

persisted over 40 days, autologous with a median survival of 43 days and non-autologous with a
median of more than 57 days, and the generated survival curves were statistically similar
(p=0.3668).
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Figure 6: Autologous and Non-autologous Pigtailed Macaque Nasal SA Strains may be
Implemented in Successful Nasal Carriage Studies
Animals’ nostrils were inoculated with 104 CFUs of SA in two independent inoculations with
either genetically distinct (non-autologous) or indistinct (autologous) from their screening isolate
as determined through MLST and spa typing. Nasal swab samples were plated on TSA II
weekly to quantitate SA CFUs longitudinally. A) Positive nasal SA counts were averaged per
individual and separated based on if the SA present was autologous or non-autologous to that
animal’s original nasal strain, with statistically similar (p=0.1281) supported SA loads.
Autologous n=31, non-autologous n=54, as most of the non-autologous data was collected
during an extended follow-up duration, ~4 weeks longer than the inoculation including most of
the autologous data collections. B) Percent survival was determined from these same
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longitudinal carriage data points, with SA detection in one nostril considered survival as all
nostrils were treated with the same inoculum in the two independent studies. Autologous and
non-autologous strains survived statistically similar (p=0.3668) for over 40 days.
Pigtailed Macaque SA Strains are Genetically Similar to Several Human Isolates
The final inoculation was a short pilot study in which it was desired to determine if the
nostrils and immunity of the pigtailed macaques would allow the colonization of a human SA
strain. The three pigtailed macaque SA strains isolated in this study were genetically compared
to seven prior human study nasal isolates as well as prototypical human wound MRSA isolate,
USA300 (wound isolate NRS384, ST8/t008) [75] to determine if the lab already possessed a
suitable human strain as similar to the macaque’s strains as possible to establish carriage. All
nasal SA strains (Table 2), whether human or pigtailed macaque (other than USA300), were
lacking the mecA gene that codes for methicillin resistance as determined through the absence of
a band in a DNA gel following PCR amplification using mecA primers. At the beginning of this
study, multi-locus sequence typing (MLST) was performed for seven housekeeping genes for
every strain to identify each isolate’s sequence type. These seven MLST DNA sequences were
concatenated per strain, aligned against each other, and arranged into a phylogeny tree according
to sequence similarity using MrBayes v3.2 phylogenetic analyses (Fig. 7). Human donor (D)
579 carried ST398 and was found to be genetically similar to macaque strains ST3814 and
ST3815 (based solely on MLST gene sequences). It was desired for the last pilot study to
implement a non-virulent, antibiotic susceptible human strain with similarity to the SA detected
in this cohort to avoid harm to the animals and to yield as much information as possible. These
comparisons heavily influenced the selection of which human nasal SA isolate was implemented
in the pilot trial involving experimental inoculation of a human SA nasal isolate into the nostrils
of the pigtailed macaques.
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Figure 7: Nasal SA Isolates from Six Captive Pigtailed Macaques are Genetically Related to
Human Nasal Carriage Strains
Evolutionary relationships between 8 human and 3 macaque nasal SA isolates in were analyzed
using Bayesian analyses. Seven MLST loci per strain were concatenated, then aligned together
and arranged into a phylogeny according to sequence similarity using MrBayes v3.2
phylogenetic analysis. Human isolate D579 (ST398) was chosen for experimental pilot
inoculum based on genetic MLST similarity to macaque isolates ST3814 and ST3815. The
average standard deviation of similarity between samples was 0.00157. Scale bar of 0.002
indicates number of substitutions per site. Numbers at each node are indicative of posterior
probability support.
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Nasal Colonization of Human Isolate ST398 was Successful and Comparable to Human SANC
Following the autologous and non-autologous inoculations of pigtailed macaque SA
isolates ST3813 and ST3814, animals were cleared of SA with mupirocin and the nasal
microbiome was allowed to normalize over four weeks. Sufficient funding remained for a 22day pilot study implementing human SA isolate ST398 using identical protocols and inoculum
size as previous macaque inoculations.

Figure 8A displays that nasal colonization was

successful in all six subjects, as indicated by log-transformed averages of each animals’ left and
right nostrils (animal ID in legend on the right) over the duration of the study period. Two
animals (A10023 and A11236) naturally cleared the SA within 2 weeks, while the remaining
four animals maintained carriage until force-cleared with mupirocin on day 22. Animals were
returned to the colony after all sites were verified cleared on day 28 post-inoculation. This study
was abbreviated and did not allow determination of the possible duration of carriage of the four
that maintained carriage, or if the two that cleared would eventually swab positive again. The
preceding macaque strain inoculations were each at least 63 days, and most extranasal sites
eventually swabbed positive for SA within that time. Figure 8B shows the SA load days 2-22
for the nostrils and all extranasal sites, each dot representing a log-transformed CFU count for
one animal (6 animals, 4 swab dates). As seen previously, the nostrils carried significantly
higher than all other sites (p<0.0001), indicated by a double asterisk. The pharynx supported
higher SA loads than the other extranasal sites (p<0.005) but not close to the nostrils, indicated
by a single asterisk. This is indicative that the shortened study duration was not conducive to
establishment of extranasal acquisition of the inoculum, however like previous inoculation
studies, the pharynx acquired carriage of the same strain once the nostrils were detectable.
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Figure 8: Experimental Inoculation of Human Nasal Isolate ST398 Established Nasal Carriage in
all Subjects
Macaques were cleared of SA as described in Materials and Methods and reinoculated with 104
CFU/nostril of human isolate ST398. Nasal and extranasal swabs were collected weekly for SA
quantification. A) Averaged nostril SA CFU/swab for each animal shows carriage was
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established in each subject with two animals clearing within 22 days, while the remaining four
subjects carried until cleared by mupirocin. Legend to the right indicates Animal IDs. B) SA
load days 2-22 in the nostrils and extranasal sites. Double asterisks indicate elevated SA load
compared to all other sites (p<0.0001). Single asterisk indicates elevated SA load compared to
axillae, palms, and vagina (p<0.005). Error bars indicate mean±SEM, n= 24 (6 animals, 4 swab
days). A, B) y-axis begins at the limit of SA detection (10 CFUs/swab).

Discussion
Prior to any experimental inoculations, the first step of this study was determining
whether pigtailed macaques (Macaca nemestrina) at the Washington National Primate Research
Center (WaNPRC) naturally carry SA in the nose, as this is a major drawback to attempting the
use of rodent models for SANC. Thirteen of seventeen animals were found to carry SA in at
least one nostril in the first screening visit, and fourteen were positive two months later (Fig. 1).
Most animals were also positive in the pharynx at one or both visits. An important finding to
note is that macaques carry nasal SA at a significantly higher rate than humans, with 14 of 17
(82%) screened pigtailed macaques in this study and 82% of 48 rhesus macaques in a
longitudinal study [56], compared to an approximate third of healthy adults carrying worldwide
at any given time [14, 15]. Previous human studies have attributed increased carriage rates in
close quarter populations that may have less than ideal sanitation like prisons, retirement homes,
daycares, and schools [4,5], and captive monkeys live in close contact and their hygiene is
lacking. Access to wild pigtailed macaques is extremely outside of our scope, as they are native
to Thailand, Malaysia, and Indonesia, therefore it cannot be said definitively that all pigtailed
macaques are natural nasal carriers of SA. The likelihood, however, that nasal carriage in this
population is a result of living in captivity and being cared for by human handlers is low, as the
caregivers go to extreme measures to prevent the transmission of microbes by wearing personal
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protective equipment including: full-coverage garments, face masks, face guards, and doubleglove their hands. Each strain isolated from the chosen subjects was identified as new, with new
MLST and spa types (Table 2), which is suggestive that natural SA carriage of this cohort of
macaques is not likely transmitted through human handling. Prior clinical evaluations have
shown that most babies are colonized with SA within hours after birth, and usually identical to
the mother’s nasal strain [81, 82], but husbandry records at the WaNPRC validate that the four
animals sharing an autologous strain are not related and are not all housed together, with SA
negative animals co-inhabiting with SA positive animals according to animal housing charts
(records not shown).
In humans, the anterior nares have been accepted as the site of predominant SA carriage
since SA is extremely adaptive to that low nutrient, high saline environment. Prior to invasive
surgical procedures, 2% mupirocin antibiotic ointment is applied to the nostrils to prevent
autoinfection, and this is sufficient to also eradicate SA from the rest of the body, as the nose
serves as a reservoir to spread SA through passive hand to face contact. This study implemented
the same antibiotic ointment with an identical regimen, identical to what is applied to humans
pre-surgery. The three pigtailed macaque isolates were susceptible to mupirocin in vitro (Fig. 2)
and in vivo (Fig. 3A), and just like pre-surgical humans, mupirocin cleared not only the nostrils,
but also the rest of the body as indicated through the observable absence of β-hemolytic colonies
on blood agar plates. This suggests that in the pigtailed macaque, the nostrils also serve as a
reservoir for SA, spread to the rest of the body through casual hand-to-face contact. It was not
determined how long the subjects would retain SA negative status in the absence of experimental
inoculation, but the nostrils, pharynx, axillae, palms, and vagina remained mostly clear of SA for
four weeks prior to each separate inoculation.
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This demonstrates that a common human

antibiotic is effective in clearing the primary reservoir of SA in the pigtailed macaque, also
clearing the body similar to humans.
Development of a protocol for SA eradication and recolonization like prior human studies
was a main goal, with a giant step forward in the introduction of a variety of strains to the
nostrils of the pigtailed macaque. Once subjects were cleared of SA, recolonization was required
implementing an appropriate inoculum that would introduce just enough SA to establish nasal
and extranasal carriage in most subjects, while also avoiding the abrupt introduction of an
excessive inoculum that may erroneously overload the nasal mucosa.

A human-relevant

inoculation of 104 SA CFUs delivered in 20uL to both nostrils was sufficient in re-colonization
of each subject after mupirocin clearance. (Fig. 5). This is an important finding, as a prior Cole
laboratory survey of 30 healthy human carriers in 2016 determined a range of SANC from 101 to
106 CFUs per nostril, with a median of 9.8 x 104 SA CFU per nostril [58]. This same humanrelevant inoculum was successful in establishing nasal and extranasal carriage in all subjects for
a total of four independent experiments (Figs. 5 & 8), significantly not requiring millions of SA
CFUs like rodent models.
A significant limitation to human SANC research in the U.S. is the inability to implement
SA inoculations other than the subject’s own nasal isolate, which prevents understanding
adhesion and virulence mechanisms of potentially virulent or antibiotic resistant strains. The
possibility of inoculation studies with a variety of strains would present a means to longitudinally
observe colonization and pathogenesis of non-autologous strains in a human-relevant model. In
two independent studies, 104 SA CFUs of a macaque isolate (3813 and 3814) was introduced to
the nostrils of all animals regardless of whether it was autologous or not to the nostril and
followed for several weeks. Autologous and non-autologous macaque strains were supported
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similarly, with both approximate means of 104 SA CFUs (Fig. 6A). Autologous and nonautologous strains also survived similarly in the macaque nostrils for over 40 days (Fig. 6B),
determined from SA-positive status in at least one nostril (considered survival as all nostrils were
treated with the same inoculum). This implicates the usefulness of the pigtailed macaque in a
variety of SANC strain inoculation studies with a physiologically relevant inoculum.
A concluding three-week pilot study that was designed to determine if there was potential
for a human SA isolate to establish carriage in the pigtailed macaque with the same
physiologically relevant inoculum that was sufficient in the macaque strain inoculations. Human
donor 579 (D579) carried ST398, a strain implicated as a host-species-adaptable methicillinsusceptible SA that can acquire resistance [84, 85].

ST398 is commonly associated with

livestock (cattle, pigs) and meat-processing and is often transmitted to humans in these lines of
work [86, 87], and was determined genetically similar to two macaque isolates through
comparisons of concatenated MLST sequences (Fig. 7). Two animals naturally cleared the
nostrils by day 22, while the remaining four subjects carried an average of 2.7x105 SA CFUs per
swab until to mupirocin clearance. The 22-day duration of this pilot study was not sufficient for
the majority of extranasal sites to acquire SA from the nose, but as seen in prior macaque
inoculations, the nostrils were the primary reservoir with significantly higher SA loads, and the
pharynx contained the highest of the extranasal sites (Fig. 8B). Prior inoculation durations were
for at least eight weeks of follow-up, so given more time the extranasal sites would acquire
increased SA loads. This data demonstrates that the pigtailed macaque can acquire and maintain
carriage of clinically-relevant human strains in addition to non-autologous pigtailed macaque
isolates, which has major future SANC research implications.
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Throughout each of the four inoculation studies, MLST and spa typing for sequencing
analysis was performed periodically to ensure that the SA colonies detected were identical to the
inoculated strain and not a genetically distinct strain. At least two MLST loci and the spa type
were required to match to be considered “genetically indistinct”. These analyses were performed
at times when i) an animal swabbed positive for several consecutive weeks, ii) times when the
nostrils swabbed positive after extended periods of undetectable SA, and iii) the last positive
swab on each extranasal site for each study. Detection of a strain genetically distinct from the
inoculum was rare, however did occur in the first study in which the appropriate inoculum was
determined. This was a rare occurrence, with extranasal SA matching the inoculum in 105 of
110 (95.5%) of the analyzed swab samples, and this did not occur in any of the other three
independent inoculations. These animals were housed in separate cages, with only visual contact
with each other, suggesting that this alternate SA strain may have been introduced in their food
supply, as these animals were not housed together prior to this study.
Longitudinal analysis of SANC in Macaca nemestrina elucidated patterns of carriage
observed in prior healthy human studies. Most human carriers are intermittent, with the ability
to clear SA to undetectable levels, then swab positive again. Some human carriers are persistent
and never appear to clear, and some appear to not carry at all, and the reasons and mechanisms
for healthy carriers to support SA in the nares and the body asymptomatically are not fully
understood. Similar carriage patterns were seen in the macaque subjects over several weeks of
follow-up over the course of the 18-month study, therefore it will be highly beneficial to analyze
the immune response during times of SA nasal carriage and clearance.

49

CHAPTER 3: ANALYSIS OF THE PIGTAILED MACAQUE NASAL
RESPONSE TO SANC REVEALS SIMILARITIES TO THE HUMAN
CONDITION
Introduction
Until now, the nasal innate immune response to SA has not been characterized for the
pigtailed macaque.

The majority of pigtailed macaque research has centered on potential

microbicides, HIV, and other human sexually transmitted diseases, with tissue structure, clinical
presentations, and immune responses similar to the human condition [66, 72]. Previous research
implementing this model found similarities in fetal development of the respiratory system and
immune function in pigtailed macaques [67, 68] therefore parallels are expected in innate
responses in the nasal mucosa in the presence of SA. In humans, however, the pro-inflammatory
response to SA in the nose has been well documented, although the mechanisms are not fully
elucidated due to the complexities of the associated relationships. Dual PRRs, TLR-2 on the
surface of phagocytic nasal mucosal cells and cytoplasmic NOD2 sense the presence of
conserved gram-positive cell wall proteins either through direct contact or protein turnover
during biosynthesis. This mounts an immune response that either effectively clears the invasion
or further promotes inflammation that potentially damages the tissue [88]. Recognition of SA by
nasal cell PRRs in the skin elicits redundant pathways to the nucleus to up-regulate expression of
AMPs and contributes to rapid innate activation. Various pro-inflammatory cytokines and
chemokines are up-regulated in response to SA presence; acting to recruit neutrophils through
diapedesis to infected tissue and maturation once they arrive [89]. Once matured, neutrophils
release oxidative bursts, sequester nutrients, produce more AMPs, and use phagocytosis to digest
SA cells encountered in the tissue [25, 90, 91], thus, defects in pro-inflammatory proteins,
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receptors, mechanisms, or decreased neutrophil volume can allow for SA persistence in the
nares.
Previous studies in the Cole laboratory centered on host factors contributing to SANC
have elucidated significant relationships between several key pro-inflammatory mediators and
the introduction of SA to the nose. In humans, enhanced expression of IL-8, IL-1β, macrophage
inflammatory protein (MIP-1β), monocyte chemoattractant protein-1 (MCP-1), granulocyte
colony-stimulating factor (G-CSF), and a decreased IL-1 receptor antagonist to IL-1β (IL1RA:IL-1β) ratio detected in nasal fluids at post-inoculation time points as compared to preinoculation were associated with SA clearance groups only [28, 58]. IL-1β is a significant
inflammatory marker that first exists as a precursor that requires cleavage into mature IL-1β by
caspase-1, induced through inflammasome activity [92] and heightens the inflammatory state
once secreted into infected tissues. Inhibition of IL-1β signaling occurs through non-productive
competition due to high levels of the IL-1β receptor antagonist binding at the cell surface IL-1
receptor [91]. Interestingly, dysregulation of IL-1β has been implicated as the primary cause of
inflammation in pancreatic islet cells, leading to progression of Type II diabetes [93], which is
known as a major risk factor of SANC. Rapid up-regulated transcription of the IL-8 gene results
in chemotaxis of neutrophils to the site of infection and induces phagocytosis once they reach
infected tissue, clearing SA more quickly than a delayed reaction [58]. MCP-1 and MIP-1β are
monocyte and leukocyte chemoattractants produced by activated macrophages that further
induce pro-inflammatory pathways in response to presence of SA [94, 95]. Examination of the
pigtailed macaque innate response will focus on these pro-inflammatory mediators as well as a
few others implicated as relevant to the SA response or lack there-of in other studies. Rodent
SANC studies have shown that IL-17 deficiency is responsible for decreased AMP production
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and increased carriage duration of SA as compared to wild type animals [55]. Induction of proinflammatory cytokines IL-6 and TNF-α has been observed in humans to be elevated in obesity
[96], which is an additional risk factor for SANC.

Addition of SA peptidoglycan to

keratinocytes in vitro triggers up-regulation of vascular endothelial growth factor (VEGF), which
has been observed in vivo to be associated with SA-associated psoriasis [97]. Highly expressed
in the nasal environment, VEGF increases permeability of capillaries, increasing fluid influx into
inflamed tissues, which facilitates influx of white blood cells [98].
Previously shown, the pigtailed macaque is easily decolonized of SA in the nose and
body with a common human antibiotic often applied to pre-operative humans, and they remained
decolonized through four weeks of nasal microbiome equilibration. Re-colonization of several
animals is easily established and reproducible with autologous and non-autologous strains using
a human-relevant inoculum of 104 SA CFUs per nostril. Nasal carriage of SA inoculations in
this cohort of six pigtailed macaques was followed longitudinally over 18 months, and this data
will be implemented in comparing subsequent detection of the 10 pro-inflammatory mediators
just discussed to the presence or absence of SA in the nasal mucosa. This will allow further
comparison of this proposed model to the human condition based on importance of certain
proteins in the innate response, as well as differences in expression in the nasal mucosa of
animals that were successful in clearance of SA from the nares to those that maintained carriage.

Materials and Methods
Blood and Nasal Fluid Collection and Processing.
Each week, 3-5 mL of blood was collected into serum separating tubes to acquire 1-2 mL
serum, stored at -80°C until use. Nasal fluid was also collected each week by inserting two
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Whatman 540 low-ash filter paper strips (0.3 x 2.4 cm) into each nostril and massaging the
exterior of the nose for 30 seconds. Paired left and right nostril strips were stored in separate
tubes at -80°C. Frozen serums and nasal strips were batch-shipped at the end of each inoculation
study on dry ice to the Cole laboratory for subsequent processing and analysis. Nasal fluid
proteins were extracted from paper nasal strips by vigorously vortexing for 20 minutes in 900 μL
of 10% glacial acetic acid (in molecular grade water), transferring the supernatant containing
soluble proteins to a fresh tube (on ice), then an additional vortex of strips with 500 μL acetic
acid for 10 minutes. The supernatants were combined per animal nostril, balanced in a SPD1010
Speedvac (ThermoFisher), and vacuum dried ≤100 μL using consistent 45° C heat. Two washes
were performed with molecular grade water and re-evaporating to a ring of moisture. Dried
samples were resuspended in nine parts Dulbecco’s Modified Eagle Media (DMEM) with 1%
BSA and one-part RIPA buffer (50mM Tris, 150mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS), and then neutralized to approximately a pH of 7 using 1N or 10N
sodium hydroxide as needed in 1μL increments. Samples were standardized to 130μL per
extract, then insoluble debris was clarified by centrifugation (10,000 x g for 1 min) and stored in
65μL aliquots at -80°C until protein analysis. Total protein was quantified with an average of 9
mg/mL with consistency between subjects. Six of 188 extracts were eliminated from Luminex
analysis due to unreadable protein quantifications, either due to insufficient collection or blood
content.

Total Protein Quantification Assays.
Select nasal protein extracts were chosen to validate the acid extraction process and
quantify total proteins by implementing the bicinchoninic acid assay (Micro BCA Protein Assay
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Kit, Thermo Scientific, Rockford, IL Lot #PD199651).

Standards were made by diluting

2mg/mL bovine serum albumin (BSA) stock with DMEM/BSA/RIPA diluent 1:10 for 200
μg/mL, which was then diluted 1:1 to create 100, 50, 25, 12.5, and 6.25 μg/mL BSA standards.
BCA working reagent was mixed according to manufacturer’s directions, and 150 μL of
samples/standards was combined with 150 μL working reagent on a 96-well clear-bottom plate
(TPP/ Midsci, cat# TP92096), with standards ran in duplicate. Controls included were molecular
grade water and any buffers used to ensure no protein contamination. The plate was covered and
incubated for 2 hours at 37°C, then removed from heat and allowed to cool to room temperature
while setting up the SpectraMax 190 microplate reader (Molecular Devices, Sunnyvale, CA).
Protein content is directly proportional to the intensity of purple color created in a two-step
reaction between copper and proteins in the solution, which is measured in absorbance.
Absorbance was read at 562nm according to manufacturer’s instructions, and protein content
was determined by correlating absorbance of samples with absorbances of known concentrations
of a duplicated standard curve.

Multi-plex Bead Immunodetection Assays.
Nasal protein extracts and serum aliquots corresponding to sample date were thawed on
wet ice prior to multiplex bead assay. A custom ProcartaPlex non-human primate 10-plex
cytokine assay (Life Technologies Corporation, Carlsbad, CA) was performed for detection of
G-CSF, IL-1β, IL-1RA, IL-6, IL-8, IL-17α, MCP-1, MIP-1β, TNF-α, and VEGF. Manufacturer
instructions were followed step-by-step for preparing standard curves, serum dilution, incubation
times, and instrument settings.

Left nostril extracts were analyzed for 3 of 4 inoculation

experiments (n=6 each) and right extracts were used for the other to best utilize observed
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transitional negative to positive SA detections. Nasal protein extracts (54μL) were mixed with
6μL of DMEM/5% BSA so both the standards and samples were diluted in a nearly equivalent
mixture of DMEM, RIPA, and .5% BSA to create a protein background and to prevent
aggregation of target proteins and non-specific adherence to the wells of the 96-well plate. A
final volume of 50μL per well of prepared standards and samples was combined with antibodyconjugated beads and washed using a Bio-Rad Bio-Plex Pro II wash system. Completion of
washes and samples readings were performed using a compatible high-throughput Bio-Plex 200
reader (Luminex xMap technology). All standard curves exhibited good fit down to 0.5-4 pg/mL
with detection limits included in figures. Data is presented as log-transformed pg/mL for both
nasal fluid extracts and serums as they were processed by equal volumes.

Statistical Analyses.
BCA and Luminex multi-plex bead protein detection assays were analyzed using
GraphPad Prism 7 software (GraphPad Software, La Jolla, CA). Prior to analyzing all extracted
nasal fluids, reproducibility of analyte detection was validated in nasal fluids by pooling four
animals’ nasal fluid extracts from one sample date and dividing into four wells for detection.
Validation of low-level detection reproducibility in serum was determined through running one
animal’s serum from one sample date in triplicate for detection of analytes. Both were found to
be highly accurate and reproducible.

SA-negative to SA-positive transitional cytokine

comparisons per individual were analyzed for significance using paired t-tests (two-tailed) (Fig.
12). Carriage durations for noses with different peaks of inflammatory proteins detected in nasal
fluids were compared using ordinary one-way ANOVA with Tukey’s multiple comparisons test
(Fig. 13).
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Results
The Nasal Fluids of Humans and Pigtailed Macaques Contain Comparable Total Protein Levels
Six pigtailed macaques were sampled for nasal SA beginning with pre-mupirocin time
points, for four weeks post-mupirocin, inoculation day zeros, day 2 or 3, then for several weeks
following inoculation. After nasal swabbing with flocked swabs, nasal proteins were collected
through wicking nasal fluid onto paper strips (Whatman 540) and blood was drawn to separate
out approximately 1mL serum. Adsorbed nasal fluid proteins were extracted in 10% glacial
acetic acid, concentrated with a total of three desiccations (with molecular water as a diluent in
between), and neutralized in a pH buffer compatible with protein quantification assays and
Luminex-based multi-plex bead assay of pro-inflammatory cytokines, chemokines, and growth
factors. Human nasal secretions (14 humans, 1 collection each) were self-collected via suction
catheter, and total protein as measured through bicinchoninic acid assay (BCA) averaged 5.5±2.5
mg/mL (mean±SEM).

Pigtailed macaque nasal secretions (6 macaques, average of 14

collections each) were comparable to human nasal fluid protein content at an average of 9.9±3.1
mg/mL total protein (Fig. 9). For the macaque data, only the extractions of non-bloody are
included, as bloody strips yielded 2 to 4-fold higher protein detections as detected through BCA.
Nasal fluids collected from animal Z08202 had frequent visibly bloody strips, therefore had the
fewest data points, but strips consistently contained higher amounts of protein than other
animals.
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Figure 9: The Nasal Fluids of Humans and Pigtailed Macaques Contain Comparable Total
Protein Levels
Following acid extraction of macaque nasal strips, soluble nasal fluid proteins were quantified
and compared to human nasal fluid protein content in mg/mL (mean±SEM) collected through
self-applied suction catheter. For the macaque data, these were the extractions marked “nonbloody”, as bloody strips yielded 2-4-fold higher protein values as detected through BCA
colorimetric assay, n=14 human nasal fluids, n=7-28 macaque nasal fluids per individual
depending on blood content of strips.

SANC is Asymptomatic in Both Humans and the Pigtailed Macaque
In healthy human hosts, SANC is mostly asymptomatic, unless the host at some point
becomes immunocompromised, which increases the risk for dangerous invasive skin infections
leading to systemic infections like bacteremia. Systemic responses to an infection cause signs of
illness such as fever, malaise, and behavioral changes like loss of appetite. Throughout this 18month study, the cohort of six pigtailed macaque subjects were monitored daily for any adverse
changes in condition or behavior. Body weight and temperature remained within a normal range
as they were measured each week as the animals were sedated for mupirocin applications or
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sample collections. Appetites and thirst remained constant as indicated through daily protein
biscuit counts reported by the animal husbandry staff. There were no discernible changes in
behavior throughout the study, nor any reports of malaise or illness, suggesting that SANC in the
pigtailed macaque is asymptomatic. Other than observable signs of illness caused by a systemic
inflammatory response, increased expression of pro-inflammatory proteins would be detected in
the blood following experimental inoculations. Figure 10 displays detection of IL-8 and IL-1β
in the nasal fluid compared to serum, as these were two key pro-inflammatory mediators in the
human innate response to SA inoculation.

Figure 10: Asymptomatic SANC does not Elicit a Systemic Response in the Pigtailed Macaque
Pigtailed macaque nasal fluids and serums were collected on day 0 directly prior to inoculations,
day 3, then weekly until the end of follow-up periods. Nasal fluids and serums for each of the
four independent experiments were assayed for ten analytes using multi-plex bead assays and
flow-based enumerations, with IL-8 and IL-1β detections shown in closed circles (nasal fluid
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detection) and open circles (serum detection). Values are shown for paired transitions from
times at which SA was not detected on TSA II agar plates either prior to inoculation or if the
animal naturally cleared the assayed nostril (neg SA), to the next sample corresponding to SA
positivity on TSA II plates (pos SA). Error bars represent mean±SEM.

These are paired comparisons of expression from samples transitioning from SA-negativity to
SA-positivity from days 0-14 of each study.

Absence was either prior to experimental

inoculation or if the animal had naturally cleared SA, and presence was the first sample at which
SA was detected on TSA II agar. IL-8 and IL-1β were both significantly up-regulated in the
nasal fluid when SA was present (p=0.0098 and p=0.0350 respectively), but not in the serum
which indicated a local innate immune response rather than a systemic response. In fact, there
was no up-regulation of any of the ten analytes in the serum (data not shown), and animals did
not display any visible symptoms of illness over the course of the 18-month study. which
strongly suggests that the response in the pigtailed macaque to SANC is local to the nasal
mucosa only as it is in the human condition.

Clearance of Experimentally Introduced SA is Reliant on Appropriate Shifts in Nasal Mucosal
Expression of Neutrophil-associated Inflammatory Mediators
Nasal fluids were assayed with a 10-plex non-human primate-specific antibody profile to
simultaneously measure the presence of IL-8, IL-1β, IL-1RA, MCP, MIP-1β, IL-17A, G-CSF,
VEGF, IL-6, and TNF-α. Previously discussed, human studies have elucidated relationships
between the local innate response indicated by levels of detection of several key inflammatory
mediators and the SA load present in the nostrils. When SA is present, more neutrophilassociated proteins are produced by the nasal mucosal cells than when SA is absent for the
purpose of recruiting neutrophils to the site of infection to aid in clearance. For four total
independent inoculation studies, pigtailed macaques were cleared of SA by a five-day mupirocin
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regimen, the nasal microbiome was allowed four weeks to normalize, and on “Day 0” animals
were swabbed, and nasal proteins were collected, followed immediately by inoculation of SA.
All animals were confirmed clear of SA on inoculation day by the absence of both β-hemolytic
colonies on TSA II and purple colonies on CHROMagar. Figure 11 shows paired transitional
detections of analytes in individual animals’ nostrils as they transitioned from SA-negative (neg
SA) to SA-positive (pos-SA). These data points were further striated depending on whether the
animal cleared SA (open red circles) from the analyzed nostril or carried consistently (green
open circles) until conclusion of the follow-up period. Like the human condition, up-regulation
of IL-8, MCP-1, and IL-1β corresponded to the individuals that cleared SA from the analyzed
nostril. In addition to the increase in IL-1β expression in SA clearers, expression of the IL-1
receptor antagonist (IL-1RA) did not significantly change, resulting in an approximate 10-fold
decrease in the IL-1RA:IL-1β ratio in the clearance group (Fig. 11C). IL-1β expression was a
bit higher at baseline in the carriers than the clearance group, but SA carriers lacked the upregulation of IL-1β; however nasal mucosal cells significantly up-regulated the IL-1RA, with no
change in the IL-1RA:IL-1β ratio. Expression of MIP-1β increased when nostrils transitioned
from SA-negative to positive regardless of whether that nostril cleared or not, and detection of
both TNF-α and IL-17A remained low in most samples (<10pg/mL) (data not shown). IL-17A
has been implicated as a key cytokine in murine SANC experiments, but it does not appear to be
important in the human or pigtailed macaque response to SA inoculation in the nose. These data
together are suggestive that like human SANC, dysregulation of neutrophil-associated proinflammatory protein expression and the IL-1 pathway in pigtailed macaque nasal mucosa lends
to sustained carriage of SA in the nose, likely due to decreased neutrophil influx and decreased
production of antimicrobial peptides.
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Figure 11: Clearance of Experimentally Inoculated SA from the Nares is Reliant on Appropriate
Shifts in Nasal Mucosal Expression of Neutrophil-associated Inflammatory Mediators
61

Macaques were cleared of endogenous SA and reinoculated with various strains as described in
Materials and Methods. Nasal swabs and nasal fluids were collected at days 0 and 3, then
weekly following nasal inoculation with SA. Luminex multi-plex bead assays were used to
detect pro-inflammatory mediators in nasal fluids. Cytokines A) IL-8, B) MCP-1, and C)
relationships between IL-1β and its receptor antagonist, IL-1RA are shown as paired transitions
from times at which animals were negative for SA (neg SA) to positive for SA (pos SA). Data
was further striated into groups of those that naturally cleared the assessed nostril of SA (SA
Clearers, red open circles) or maintained carriage for the duration of the study (SA Carriers,
green open circles). Error bars represent mean±SEM.

Duration of SANC in Pigtailed Macaques Associates with Peaks in Expression of Inflammatory
Markers
The Cole laboratory has previously conducted human SANC experiments in which 43
healthy adults self-applied mupirocin ointment to clear the nostrils of SA, then self-applied their
own isolate again into each nostril [28, 58]. Subjects were swabbed in the nostrils, followed by
nasal fluid collection via suction catheter on days 0 and 3, then weekly for a month of follow-up
to compare SANC with nasal mucosal expression of pro-inflammatory proteins. Peak expression
of IL-8 and IL-1β within 7 days correlated with shortened duration of SA nasal carriage, an
average of 19±3 (mean±SEM) days, while a delayed response of ≥16 days correlated with longer
carriage or no clearance at all [58]. Seen over the course of three independent inoculations,
pigtailed macaques displaying peak expression within the first 7 days post-inoculation cleared
SA within an average of 11±3 days, and the absence of peak expression or a delayed response of
16 days or more resulted in nasal carriage of at least 40 days (Fig. 12). Three animals with peak
expression at 16 days post-inoculation or later maintained carriage until the final day of followup (red circles) and would have likely continued nasal carriage in the absence of antibiotic
clearance. These points together suggest that IL-8 and IL-1β function similarly in humans and
the pigtailed macaque, and appropriate up-regulations of these key inflammatory mediators in
the nasal mucosa drive duration of Staphylococcus aureus nasal carriage.
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Figure 12: Duration of SANC in Pigtailed Macaques Associates with Peaks in Expression of Proinflammatory Mediators
For each of the 18 macaque inoculations, peak nasal expression of pro-inflammatory proteins IL8 and IL-1β was assessed by Luminex multi-plex bead assays of extracted nasal fluids.
Occurrence of peak detections (x-axis) per individual was plotted against duration of SANC in
days (y-axis), error bars indicate mean±SEM. Red-filled circles indicate individuals that were
still positive for SA in the assessed nostril on the final day of follow-up (thus SA carriage was
likely longer).

Discussion
Previous human SANC studies have proven that human local responses to SA inoculation
in the nose are neutrophilic in nature with observations of rapid and robust up-regulations of IL8, IL-1β, and a decrease in the ratio between IL-1β and its competitive receptor antagonist (IL-
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1RA) in human hosts with the ability to clear SA from the nose [28, 29, 58]. Human IL-8 is a
chemokine that recruits neutrophils to the site of infection, and its increased expression is
correlated with increased detection of SA CFUs [32], also observable in pigtailed macaque
sample detections. The quick up-regulation of expression of the IL-8 gene is vital to human
clearance of SA, and if it is not correctly regulated, SANC will likely persist. This aspect of
human SANC is not modeled in rodents, not even in the more physiologically relevant cotton rat
as the IL-8 gene is absent, however in the pigtailed macaque it is not only present, but functions
similarly as it does in human SANC (Fig. 11A).
Staphylococcus aureus nasal carriage in humans is typically asymptomatic, even when
SA is detected in the millions of CFUs per swab in healthy hosts [58]. Although the reasons and
mechanisms behind this asymptomatic state is not well understood, the human innate response to
SA presence is heavily neutrophilic, with local up-regulations of IL-8 and IL-1β in nasal fluid,
among others [28, 29, 58]. Pigtailed macaque nasal mucosal cells also significantly up-regulate
expression of IL-8 and IL-1β (p=0.0098 and 0.0350 respectively), with no systemic upregulations detected in the serum (Fig. 10).

Macaques also showed no changes in body

temperature, appetite, body weight, behavior, and no other outward signs of illness were
observed over the course of the 18-month study. Together, these data show that SANC is also an
asymptomatic state in the pigtailed macaque.
Elucidations of the pigtailed macaque responses to nasal inoculations of SA were
obtained through simultaneous detections of 10 pro-inflammatory mediators in the nasal fluid:
IL-1β, IL-1RA, IL-6, IL-8, IL-17A, MIP-1β, MCP-1, G-CSF, VEGF, and TNF-α. Prior human
SANC research showed that IL-1β, IL-8, MIP-1β, MCP-1 and G-CSF were significantly upregulated in nasal fluids of the subjects that cleared SA from the nose [28, 58]. TNF-α and IL-6
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are well-known pro-inflammatory cytokines; VEGF maintains homeostasis and remodeling of
mucosal barriers damaged by inflammation [28, 98]; and IL-17A up-regulation is the primary
response to nasal SA inoculation in rodents [15, 55]. For four independent inoculations, nasal
fluids from one nostril per individual was analyzed as they transitioned from SA-negative status
(day 0 or after natural clearance) to the next sample obtained when SA was detectable (SApositive), then further striated based upon the individuals’ ability to clear SA from the analyzed
nostril or maintain carriage (Fig 11). These paired transitions elucidate that Macaca nemestrina
accurately models the human neutrophilic response to SANC. The SA clearance group showed
significant up-regulations of IL-8 (Fig. 11A), MCP-1 (Fig. 11B), and IL-1β with a 10-fold
decrease in the IL-1RA:IL-1β ratio (Fig. 11C), indicating that like human SANC, dysregulation
of expression of these neutrophil-associated pro-inflammatory mediators in the pigtailed
macaque disrupts neutrophil diapedesis and SA clearance to allow persistence. IL-17A, VEGF,
IL-6, G-CSF, and TNF-α expression were not significantly up-regulated when SA was present,
and MIP-1β was up-regulated whether the animal cleared or carried SA (data not shown). This
data aligns with previous studies implementing this species for human sexually transmitted
infections and fetal respiratory development, each concluding that the pigtailed macaque is
currently the most-human relevant model for mucosal interface structure and immune responses
[64, 67, 99, 100].
Examining the detections of these pro-inflammatory mediators longitudinally over the
course of each of the four independent SA inoculations revealed an important correlation
between when expression of neutrophil-associated proteins and the resulting duration of SA
carriage. A peak in IL-8 and IL-1β expression within the first 7 days corresponds to 9.8±4.6
days until SA clearance, significantly shorter than 47.5±9.5 days when the peak was at 16+ days
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or not at all (p=0.0071) (Fig. 12). Three individuals indicated as red-filled circles were still
positive for SA at the end of follow-up periods and would likely continue carriage in the absence
of mupirocin application. IL-1β signaling is vital for induction of neutrophilic killing of SA by
phagocytosis, oxidative bursts, and the release of neutrophil extracellular traps (NETs), and
dysregulation of this cytokine and its non-productive receptor antagonist (IL-1RA) has been
implicated to allow persistent carriage of SA [39]. The IL-1 axis is often dysregulated in
diabetes and obesity; two risk factors for persistent SA nasal carriage that often lead to
autoinfection [101] and nosocomial comorbidities. These significant observations in this model
indicate that like human SANC, dysregulation of these pathways also leads to extended duration
of SANC.
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CHAPTER 4: THE NASAL MICROBIOME AS AN UNDEREXPLORED
DETERMINANT OF STAPHYLOCOCCUS AUREUS NASAL CARRIAGE
Introduction
Nasal microbiota structure is temporally variable and is reactive to hygiene, stress,
climate, environment, and interpersonal relationships [102], and not fully elucidated or
understood. Displaying potentially extensive diversity, commensal microflora are an additional
source of protection from pathogens through release of various protein products, and niche
competition. Disturbances in a commensal population possibly contribute to inflammation,
problematic in determining whether microbiome shifts act as the cause or the effect of SA
infection, or both [103]. Numerous studies on human nasal commensal relationships have
revealed specific species that at least partially inhibit persistent SA colonization through various
mechanisms that alter the nasal environment [104]. An inverse relationship has been observed
between SA and notable microbes like Corynebacterium spp. [45], Propionibacterium spp.
[105], Staphylococcus epidermidis, [42, 102], and S. lugdunensis [46], likely through production
of various bacteriocins [46, 102], niche competition, or competition for nutrients and surface area
for attachment [48]. These associations affect SA colonization ability, presumed to be at least
partially responsible for allowing persistent carriage in some individuals and not others in human
studies, however most of these studies have used culturable methods. It has been shown recently
through next-generation sequencing (NGS) methods that the most human-relevant rodent model
for SANC, the cotton rat, do not support any of these important bacterial species that are found
in human nostrils, but instead contain primarily Campylobacter species and potential human oral
and gastrointestinal pathogens [61]. Prior research implementing this model did not consider the
constituents of the nasal microbiome, however to validate the pigtailed macaque as a human67

relevant model of human SANC, these comparisons must be made.

Prior studies have

determined the pigtailed macaque as a physiologically relevant model for human reproductive
and rectal mucosa, and through culturable methods determined that the mucosal normal flora
endogenous to the vaginal tract is like humans in frequency of colonization with Lactobacilli
[106, 107].
Analyses of the human microbiome composition has been limited because using Sanger
sequencing requires streaking a series of different agar types, plucking colonies to incubate
overnight, extracting DNA, running 16S PCR, sending samples for Sanger sequencing, and
BLAST analysis of the results, which proves to be slow and expensive with low turnout [108].
Comparatively few species of bacteria will grow on plates, some are fastidious and require
special additions, and some proliferate more rapidly than others, leading to overrepresentation of
species with underrepresentation of others or missing them completely. Another aspect to
consider is that culturable methods only allow detection of viable cells and it would be beneficial
to determine if SA is present in the nostrils of those categorized as non-carriers either as freeDNA, dead cells, or viable but nonculturable cells (VBNC). SA frequently exists in a VBNC
state in the low nutrient environment of the nasal mucosa [109] and is likely also present in noncarriers.
Significant advancements in NGS technologies and databases in recent years have
improved acquisition of metagenomic information and have allowed this long and problematic
process to be circumvented, and instead analyze all DNA present in a sample. Illumina MiSeq
Sequencing System is a cost-effective, high-throughput system used for targeted gene
sequencing, gene expression analyses, and metagenomics that has a maximum read length of
2x300 base pairs of the 16S rRNA gene [110]. The 16S gene is 1500 base pairs that encode the
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constituent of the bacterial small ribosome that binds to the Shine-Dalgarno sequence when the
ribosome is recruited to bacterial mRNA. The gene is made up of conserved and hypervariable
regions, conserved regions being identical between bacterial species, and the hypervariable
regions being species-specific, an aspect that is exploited in improvements in next-generation
sequencing technologies [111]. The ability to identify down to genus or species level of a
population sample relies on the hypervariable region(s) of the 16S gene chosen for amplification
and the methods used, especially when several species are closely related, like those in genus
Staphylococcus [109].

For this study, the V3-V4 hypervariable regions were chosen for

amplification as it has been seen in prior research to provide the most accurate genus/species
representation [111]. A positive feature of the advancements in sequencing is that upwards of
200 samples can be combined together into one library to analyze on the same microchip by
adding a unique “barcode” not found in nature to each strand in an individual sample, so even
after combination with many other samples, the microbial species detection data can be
identified and separated apart [111].
Importantly, prior in vitro and in vivo methods in this study have shown the absence of
both mupirocin and methicillin resistance in the three nasal macaque strains and the human
isolate implemented, and all animals were successfully cleared of SA for several weeks while
allowing the nasal commensal microbiome to normalize. The six healthy pigtailed macaques
enrolled in this study are fed the same diet, treated identically, and live in climate and humidity
controlled individual enclosures, which eliminates some of the free-will factors that contribute to
fluctuations of the nasal microbiome in humans. It was evident through longitudinal plate counts
on TSA II agar plates that mupirocin application temporarily decreased the non-SA commensal
population in the nose, but by week three of the post-mupirocin normalization period that
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population numbers were restored. Although population numbers were restored by week three,
there was no way to know what commensal species were represented and what resulting
environment was created by the post-mupirocin nasal microbiome. Since mupirocin inhibits a
wide range of gram-positive bacteria, determination of the affected nasal commensal species
other than Staphylococcus aureus and observation of any microbial shifts that occur following
mupirocin application would be a beneficial addition to scientific knowledge and further
understanding of the dynamics of SANC. This study seeks to i) compare culturable components
of the human and pigtailed macaque nasal microbiomes, ii) determine culturable species affected
in one pigtailed macaque’s nose over three weeks and any microbial shifts once mupirocin opens
the niche that SA occupies, iii) compare these culturable affected species to MiSeq detections in
the same animal’s nose, and iv) compare MiSeq detections of nasal commensals in select
pigtailed macaque and human samples. This will broaden scientific knowledge as the pigtailed
macaque nasal microbiome has not been described thus far, and the use of next-generation
sequencing may provide insight to what culturable microbes are missed in plating methods.
Comparisons between the relative abundance of human and pigtailed macaque nasal inhabitants
will also provide another level of evaluation of the potential of this species as an improved model
for human SANC.

Materials and Methods
Culturable Microbiome Analyses
The natural nasal microbiome of fourteen human and six pigtailed macaque nostrils were
analyzed prior to any experimental manipulation. Representative aliquots over the course of
both human [58] and macaque studies were reserved in sterile glycerol stock at -80°C until
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further use. Selected samples were kept on dry ice to keep stock as a mostly frozen “slush”,
mixed with a sterile spatula, and approximately 100 μL of frozen slush removed and allowed to
fully thaw. This was diluted 1:10 in HBSS, and plated on an array of six agars: nutrient agar
(NA), plate count agar (PCA), CHROMagar, tryptic soy agar (TSA), tryptic soy agar/ 5%
sheep’s blood (TSA II), and mannitol salt agar (MSA). Each plate received 100 μL of sample
and was incubated 24-48 hour. Colony morphology was recorded and plucked for overnight
subculturing in 5 mL TSB (18 hrs/37°C/250rpm). Genomic DNA was extracted from these
isolates using UltraClean Microbial DNA Isolation Kit (MO Bio Laboratories, West Carlsbad,
California, USA) according to manufacturer's instructions, except instead of using 1.8 mL of
sample, 800 μL were extracted unless bacterial pellet was insufficient. 16S PCR was performed,
verified by gel electrophoresis, then sent for Sanger sequencing at Eton BioSciences (Research
Triangle Park, NC). Sequencing files were analyzed using Mega7.0.20 software to align 16S
sequences in preparation for BLAST analysis for prospective species identification. These
identifications were analyzed using GraphPad Prism 7 software.
To analyze fluctuations in the culturable nasal microbiome due to 2% mupirocin
application, the right nostril of animal Z08202 was chosen and three time points were chosen: i)
the natural balance of the nasal microbiome at the first pre-mupirocin nasal swab (prior to any
experimental manipulation), ii) week one post-mupirocin, and iii) week three post-mupirocin to
determine the natural balance of species compared to the time point at which the population was
decreased the most and when the population was restored. Early glycerol “slush” was removed
from each sample, and the remainder was quickly returned to -80°C for future use. Fully thawed
sample was serial diluted in HBSS at 1:10 and 1:100 and plated on Hoyle’s agar, TSA II, plate
count agar, and nutrient agar. These were incubated at 37°C for 24 hours (TSA II) and 48 hours
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for growth. Plates were counted, twenty colonies per plate type were documented for colony
growth morphology, plucked with a pipette tip, and each propagated in 5mL TSB overnight at
37°C in a shaking incubator. DNA extraction of each colony stock was performed and reserved
at -20°C, with subsequent PCR to amplify the 16S rRNA gene. The presence of 16S rRNA
amplification was verified through visualization of a distinct band corresponding to 1500 base
pairs after gel electrophoresis. Successful amplifications were then sent for Sanger sequencing at
Eton BioSciences (Research Triangle Park, NC).

Sequencing files were analyzed using

Mega7.0.20 software to align 16S sequences in preparation for BLAST analysis for prospective
species identification. These identifications were analyzed using GraphPad Prism 7 software.

DNA Preparation for Comprehensive Microbiome Analyses
To analyze fluctuations in the comprehensive nasal microbiome due to mupirocin
application, total DNA extractions were performed of representative “early” glycerol stocks of
Z08202 left nostril corresponding to sample dates analyzed using culturable methods. These
were fully thawed on wet ice, vortexed well, and 800 μL was transferred per sample into a
1.5mL microcentrifuge tube, reserving the remainder at -80°C for future applications. 800 μL of
each sample was spun down at 14000 xg for 10 minutes at 4°C, then 500 μL of the supernatant
was spun through a MWCO 3 Amicon Ultra filter for 20 minutes at 14000 xg to obtain a
concentrated super for inclusion in the DNA extraction process.

We modified the

ZymoBIOMICS DNA Microprep kit (Zymo Research, Irvine, CA Lot #ZRC201522) protocol to
include a heated enzymatic incubation step by resuspending each pellet in 41 μL Tris/EDTA
(TE) buffer, 50 μL (10mg/mL) lysozyme, 3 μL (4KU/mL) lysostaphin, and 6 μL (25 KU/mL)
mutanolysin and incubating at 37°C/1hr/350-400 rpm. This enzymatic incubation and additional
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spin of supernatant was to promote lysis of any hardier gram-positive cell walls present and
prevent exclusion of smaller microbes that may not have been pelleted. 200 μL of combined
pellet and retentate was DNA extracted following instructions provided.

Resulting DNA

concentrations were determined using Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen,
P11496) in a 96-well format with fluorescence read by SpectraMax i3X to ensure adequate DNA
extractions of at least 5 ng/µL. Data was exported to Excel to determine dilution schemes to
input 5ng/μL of each sample into DNA library preparation for Illumina MiSeq sequencing of the
V3-V4 hypervariable region of the 16S rRNA gene.
Using longitudinal carriage data, six human and six pigtailed macaque samples were
extracted implementing this same protocol for inclusion in this preliminary MiSeq run to
determine similarities and differences in comparative carrier and non-carrier/clearer nasal
microbiomes. Macaque samples were analyzed at days 0 and 3, weekly until day 22, then at time
points when individual animals naturally cleared SA, swabbed positive again, and either cleared
again naturally or at the last day of follow-up. Human persistent, intermittent, and non-carrier
samples were collected at less consistent time points than the macaques, but samples with at least
a 2-week period in between collections were chosen, if possible.

Illumina MiSeq Library Preparation
For this project, the taxonomic compositions of 15 samples were analyzed to determine
comparative microbiomes of healthy pigtailed macaque and human SA nasal carriers versus noncarriers/clearers. 5 ng/μL of total microbial DNA extractions from representative nasal swab
glycerol stocks were each individually entered into a first stage PCR to amplify the V3-V4
hypervariable region of the 16S gene out of genomic DNA following protocols and using
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primers and kits provided by Illumina MiSeq. This was done using previously described 341F,
785R primers [112] with universal overhang adapters upstream and downstream of the V3-V4
region.

Quality control of PCR products were run on a TapeStation system to verify the

approximate 550 bp size of the amplicon plus the two ~50 bp adapters. A cleanup step followed
using beads graciously provided by Dr. Anna Forsman at the University of Central Florida to
eliminate free primers, primer dimers, and any amplicons that were not the approximate 550 bp
size. These were then entered into a second round of PCR to add unique indices to each
amplicon in each individual sample, followed by an additional beaded cleanup to purify the final
library prior to another quantification by PicoGreen assay, and finally pooling samples into an
equimolar library. This resulting library made up of approximately 255 individually barcoded
samples in equimolar representations was sent to the University of Florida’s Interdisciplinary
Center for Biotechnology Research (ICBR), then processed using MiSeq v3 reagent kit for
optimal kinetics. Prior to cluster generation and sequencing, a denaturation process using buffers
and heat must be done, then the library is diluted, transferred to the flow cell, and run on the
MiSeq system.

Taxonomic Analyses
Percent representations of Sanger sequencing detections of human and macaque nasal
microbiome species/genera were analyzed using GraphPad Prism 7 and calculated as part of a
whole (Figs. 13-15A). Dr. Shibu Yooseph of the University of Central Florida kindly analyzed
resulting Illumina MiSeq sequence data using the USEARCH/UPARSE program suite
algorithms to rapidly search global databases and cluster sequences with a reported ≤1%
incorrect base error rate [113, 114] (Figs. 15B-17). Taxonomy was assigned to sequences
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implementing a naïve Bayesian classifier in mothur [115, 116] to define the relative abundance
of taxa present in each analyzed nostril, mostly represented at the genus level.

Results
Humans and Pigtailed Macaques Support Similar Culturable Nasal Commensals
Fourteen human and six pigtailed macaque swab fluids were diluted in HBSS and plated
on an array of agars to analyze comparative culturable natural nasal microbiomes. A total of 83
colonies were plucked from human plated samples, and a total of 182 colonies were plucked
from macaque sample plates. The relative abundance of species detected through plucking
colonies and Sanger sequencing of the full-length 16S rRNA gene revealed a majority of species
in common between humans and macaques (Fig. 13).

Figure 13: Humans and Pigtailed Macaques Support Similar Culturable Nasal Commensals
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Representative glycerol stocks from 14 human and 6 macaque nostrils were dilution plated on an
array of agars and incubated 24-48 hours, then colonies were described and proliferated
overnight in TSB for DNA extraction. 16S rRNA gene was amplified for each colony and sent
for Sanger sequencing to identify each. These preliminary investigations into the natural nasal
inhabitants of human and captive pigtailed macaques show a predominance of Staphylococcal
species in the culturable population, mainly S. aureus and S. epidermidis, as well as many
additional microbial species in common. n= 83 human and 182 macaque colony identifications.

Staphylococcal species represented the majority of 16S species identifications, with humans
supporting 72.3%, and pigtailed macaques supporting 92.9% including: S. aureus, S.
epidermidis, S. hominis, S. capitis, S. haemolyticus, S. warneri, S. pasteuri, S. simulans, and S.
patrasii.

In terms of Staphylococcus aureus representation specifically, pigtailed macaque

nostrils contained 20.3%, while humans supported 24.1%. Roughly 100 more colonies grew on
macaque dilution plates with the same dilution scheme as the human samples, indicating that as
expected, these animals support more bacteria as they lack the basic hygiene of humans. Two
major Staphylococcal species comprised roughly half of both human and pigtailed macaque total
species identifications, S. aureus and S. epidermidis, however further analyses should be
explored to determine if this is true due to competition of these common skin flora for the same
niche, or due to the bias created by using culturable methods as Staphylococcal species are hardy
and proliferate well on a wide variety of media.

Mupirocin Significantly Reduces the Nasal Staphylococcal Population Causing a Microbial Shift
To determine the effect of nasal application of mupirocin ointment to the microbiome,
one animal’s natural microbial balance in one nostril prior to any experimental procedures was
compared to weeks one and three post-mupirocin application in the same nostril (Fig. 14). These
representative glycerol stock samples were dilution plated on Hoyle’s, nutrient, plate count, and
TSA II agars, with 20 colonies per plate type (if present) identified by Sanger sequencing of the
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16S gene. Supporting prior observations of the original weekly longitudinal carriage counts,
week one post-mupirocin dilution plates showed that along with SA eradication, there was also a
significant decrease in non-SA population CFU counts that recovered by week 3 (pre-mupirocin
n=83 colony identifications, week 1 post-mupirocin n=57, and week 3 post-mupirocin n=73).
Figure 14 shows the colony species identifications that are shared between the three analyzed
time points with any identifications not shared compiled into an “other” category for clarity.

Figure 14: Application of 2% Mupirocin to the Nares Causes a Microbial Shift
Representative glycerol stocks from one individual at pre-mupirocin and weeks one and three
post-mupirocin were each individually plated on an array of agars and incubated 24-48 hours,
then colonies were described and proliferated overnight in TSB for DNA extraction. The 16S
rRNA gene was amplified for each colony and sent for Sanger sequencing to identify each at the
species level. Eradication of SA and significant inhibition of S. pasteuri provides a niche for
other less inhibited species to shift into.

In this individual’s right nostril, the natural culturable microbiome contained 6% SA (in black),
12% S. epidermidis, 6% S. hominis, 20.4% S. pasteuri, 17% Corynebacterium ulcerans, and
26.5% other species prior to any manipulation. By week one post-mupirocin, SA was eradicated,
S. pasteuri decreased by 19%, and C. ulcerans decreased by 10%, allowing a 5% increase of S.
epidermidis, a 15% increase in S. hominis, and detection of “other” species increased by 7%.
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This indicates that eradication of SA and significant inhibition of S. pasteuri and C. ulcerans by
mupirocin application, allows other species, including Streptococcus, Bacillus, Psychrobacter,
and other Staphylococcal species to proliferate into the unoccupied niche. By week three postmupirocin, S. epidermidis and S. hominis made up more than half of the species identifications,
S. pasteuri increased by 17% and the “other” species decreased by 22%, indicating a decrease in
biodiversity as Staphylococcal species flourish and outcompete other less-represented nasal
commensals.

Again, these associations were made through implementation of culturable

methods and as such are likely biased toward Staphylococcal species, however are still useful in
comparisons NGS detections.

Comparison of Nasal Microbiome Determined from Culturable Bacteria Versus a DNA-based
MiSeq Approach
The Illumina MiSeq platform was used to sequence the V3/V4 hypervariable regions of
the 16S gene of total microbial DNA extracted from Z08202’s representative glycerol stocks of
the left nostril that correspond to the same days as prior culturable analyses of the right nostril in
which the 16S gene in its entirety was sequenced from colonies grown on an array of agar plates.
Figure 15 shows genera detections through both Sanger sequencing of the full 16S gene (Fig.
15A) and MiSeq sequencing of V3/V4 (Fig. 15B). In comparing the resulting detections of
individual strands of DNA present in representative samples, it is evident that Staphylococcal
species are over-represented when using culturable methods.

Corynebacterium species are

under-represented through culturable methods, especially seen in weeks one and three postmupirocin where culturable methods only allowed detection of 22.8% and 6.8% respectively,
while in the relative abundance detected through MiSeq sequencing were approximately 55%
and 72% respectively. Week one detections using MiSeq showed very low Staphylococcal
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species representation, and approximately 50% Corynebacterium, which is very different than
culturable detections. MiSeq allowed detection of Dolosigranulum, a genus that only has one
known species, D. pigrum, which was not detected on any agar plate at any time.

Figure 15: Comparison of Nasal Microbiome Determined from Culturable Bacteria Identification
Versus a DNA-based MiSeq Approach
Comparisons of relative abundance of genera present in the nose of one individual macaque
detected through: A) Sanger sequencing of the full-length 16S rRNA gene of plated colonies
(right nostril), and B) Illumina MiSeq detection of the V3-V4 hypervariable region of all
microbial DNA present in representative samples (left nostril). The three bars in both A and B
from left to right represent pre-mupirocin, week 1, and week 3 genera detections respectively.

MiSeq also detected an unclassified Moraxellaceae family member at about 40% relative
abundance prior to mupirocin treatment, which was eradicated with mupirocin treatment. A
member of this family was identified in the pre-mupirocin culturable Sanger identifications,
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Psychrobacter pulmonis, so this is likely at least part of the unclassified Moraxellaceae detected
along with another member, genus Acinetobacter. The genus Acinetobacter was not specifically
detected in this animal’s nostrils but was detected with MiSeq in other pigtailed macaques at
many times throughout the study as well as many human samples. Comparisons between Sanger
and MiSeq showed that mupirocin treatment increased biodiversity at least temporarily as
indicated by increased detection of “other” species, indicated more clearly in Fig. 15B, as well as
the limitation of culturability that creates bias when plating samples.

MiSeq Detected Similar Nasal Microbiome Profiles in Pigtailed Macaque and Human Nasal
Samples
Illumina MiSeq sequencing of V3/V4 hypervariable regions of the 16S gene was used to
analyze the comprehensive nasal microbiome following extraction of total DNA from
representative glycerol stocks reserved over the course of a prior human study [28] and one
independent SA inoculation in the nostrils of the six pigtailed macaques. Samples were analyzed
at days 0 and 3, weekly until day 22, then at time points when individual animals naturally
cleared SA, swabbed positive again, and either cleared again naturally or at the last day of
follow-up.

Human persistent, intermittent, and non-carriers were analyzed for future

determinations of differences in nasal microbiome components, if any. Comparisons of the
relative abundance of genus-level identifications were made between three human and three
macaque samples from individuals that maintained persistent nasal carriage of SA (Fig. 16).
Staphylococcus and Corynebacterium represented more than 75% of the genus make-up of the
nasal microbiome of SA carriers, with few other genera represented in the remaining 10-20%
detections. Dolosigranulum, Acinetobacter, Streptococcus, and others were represented in much
smaller abundance in both human and pigtailed macaque samples.
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Figure 16: Pigtailed Macaque and Human Persistent SA Carriers Support Similar Genera in
Nasal Microbiome as Detected Through Illumina MiSeq
V3-V4 amplicons of the 16S rRNA gene of extracted DNA from representative sample glycerol
stocks from three human and macaque persistent carriers were sequenced implementing the
Illumina MiSeq platform. Comparative relative abundances (y-axis) of the ten most represented
genera (legend on the right) are shown, with Staphylococcal and Corynebacterium species
predominating at an approximate 80% of the detections in both human and macaque carrier
groups.

Comparisons of the relative abundance of genus-level identifications were made between three
human non-carriers and three macaques that quickly cleared SA from the nose using longitudinal
carriage data in selection of subjects to include in comparisons (Fig. 17).

These samples

contained considerably less Staphylococcal, Corynebacterium, and Dolosigranulum genera than
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the relative abundances found in nasal SA carriers (Fig. 16), but interestingly had noticeably
increased representation of Acinetobacter in both human and macaque samples at about 30%,
also with more biodiversity in most samples.

Figure 17: The Nasal Microbiomes of Pigtailed Macaques that Clear SA from the Nose
Compared with Human Non-carriers Contain a Significant Percentage of Acinetobacter
V3-V4 amplicons of the 16S rRNA gene of extracted DNA from representative sample glycerol
stocks from three human non-carriers and three macaque clearers were sequenced implementing
the Illumina MiSeq platform. Comparative relative abundances of the ten most represented
genera (legend on the right) are shown, with significant detections of Acinetobacter in each,
which was not observed in persistent carriers.
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Discussion
The components of the pigtailed macaque nasal microbiome have not been characterized
prior to this investigation into the suitability of this proposed model for human Staphylococcus
aureus nasal carriage, however previous studies have shown that the vaginal mucosal
microbiome is similar to human females [66, 71, 99, 107]. The human nasal microbiome is
underexplored due to low pressure from disease states, but it is known to vary between
individuals with many factors contributing to the species supported in the nose as well as SANC.
Initial preliminary investigations were limited by culturability on an array of agars, but did allow
determination that both macaque and human nares support Staphylococcus aureus, a feature
lacking in historic rodent models. Culturable methods also showed that representative swab
fluids contained mostly Staphylococcal species in both humans and macaques, with SA, S.
epidermidis, S. hominis, S. warneri, S. capitis, and S. haemolyticus in similar proportions in both
(Fig. 13). Application of mupirocin antibiotic ointment in the nose significantly affects the
culturable nasal microbiome, as many other gram-positive nasal commensals are inhibited along
with SA eradication. S. pasteuri and C. ulcerans were significantly decreased by week one postmupirocin, allowing S. epidermidis, S. hominis, and several “other” genera like Bacillus and
Streptococcus to temporarily flourish and occupy the niche left open in an increase in
biodiversity (Fig. 14). By week three post-mupirocin, the population counts had restored, and S.
epidermidis, S. hominis, and S. pasteuri overtook most of the culturable nasal microbiome,
decreasing biodiversity by displacing the “other” species by a 20% decrease in detection.
Realizing that culturability of microbes is a limiting factor for microbial identification,
the Illumina MiSeq sequencing platform was implemented to detect each piece of bacterial DNA
in representative samples frozen in glycerol rather than only what will grow on an array of
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plates. Comprehensive detections of representative samples using NGS methods are reliant on
the chosen method, as well as several other factors. The nasal mucosa has a relatively low
bacterial biomass as compared to the lower respiratory system and the gut, and is made up
mostly of difficult to lyse gram positive microbes. Without an enzymatic step, many cell walls
will fail to lyse, and misrepresentation of inhabitants is likely. All analyzed samples were treated
with identical enzymatic treatments and library preparation steps to maintain consistency and
prevent wasting irreplaceable representative samples.
Comparing the percentages of genera detected on plates against what was detected
through MiSeq when analyzing the effect of mupirocin on the same animal’s nose, it is evident
that Staphylococcal species are highly overrepresented using culturable methods, by 40% or
more between each of the three days analyzed (Fig. 15). The MiSeq platform allowed for a
wider range of microbial identifications that were not detected on agar plates, however culturable
methods allowed identification of Psychrobacter species, while MiSeq detected the family it
belongs to, Moraxcellaceae. MiSeq data represents a roughly even relative abundance of the
natural balance of Staphylococcal and Corynebacterium species detected in the pre-mupirocin
sample (Fig. 15B), as well as detection of Dolosigranulum, which was never detected on agars.
Week one post-mupirocin showed an increase in biodiversity, which was also reflected in
culturable identifications, but week 3 post-mupirocin MiSeq detections show that
Corynebacterium overtook the rebounded population, conflicting with culturable methods, which
showed primarily Staphylococcal species (Fig 15).

Using these sequencing methods in

conjunction with each other is beneficial to acquire additional information than either one singly
can provide.
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Preliminary comparisons between the nasal microbiomes of human and pigtailed
macaques were made implementing the MiSeq platform to determine if the nasal environment is
similar in terms of commensal factors in addition to the similarities in carriage patterns and
resulting pro-inflammatory protein expression that we have already observed.

Microbial

profiling of human and macaque persistent carrier samples revealed that the nasal microbiome is
made up of approximately 75% Staphylococcal and Corynebacterium genera (Fig. 16), which
aligns with prior findings [118, 119]. In addition, we observed a trend of similar profiles with
significant representations of Acinetobacter and decreased Corynebacterium and Staphylococcal
identifications in samples collected from pigtailed macaque clearers compared with human nonand intermittent carriers (Fig. 17). Interestingly, gram-negative Acinetobacter baumannii has
previously been implicated as a major human pathogen with the propensity to acquire drugresistance and maintain long-term concomitant persistent nasal carriage with MRSA in
healthcare settings that can become invasive and life threatening [120, 121]. There are at least
46 species within the Acinetobacter genus, and since the MiSeq did not resolve down to the
species level, we cannot assume that this detection is A. baumannii, but this genus was detected
in similar relative abundances in both human and macaque non-carrier nasal microbiomes. This
data suggests that whichever Acinetobacter species detected in these samples competes for niche
occupancy with Staphylococcal and Corynebacterium species as these were found in less relative
abundance in noses containing increased abundance of Acinetobacter. With respect to bacterial
diversity in general, it appears that the clearers/non-carriers support a more diverse microbiome
in most samples than persistent carriers in both the pigtailed macaque and human samples (Fig.
16 and 17). As previously discussed, the nasal microbiome of the most relevant rodent model
for SANC has been previously characterized as primarily Campylobacter species [61] through
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next-generation sequencing methods. Importantly, similar methods implemented in this study
did not detect any of the species identified in the cotton rat model in either human or pigtailed
macaque samples.
Prior human studies have suggested that Corynebacterium is a major inhibitor of SA
colonization in the nares [48]; however, Corynebacterium was found in all nostrils whether
positive or negative for SA, and was detected in a greater relative abundance in persistent nasal
carriers. These findings likely support other groups that have suggested that interactions with
Corynebacterium species causes a shift in SA fitness that promotes commensalism over
virulence [45], allowing prolonged persistence in the nares with decreased immune detection.
This nasal microbiome data, paired with prior research that identified similarity in the
reproductive system microbiome, supports the pigtailed macaque as a better model than rodents
for the dynamic interplay between SA and the non-SA nasal commensal population during
Staphylococcus aureus inoculation experiments. Comparisons between human and macaque
nasal microbiomes have never been made, and elucidations of the similarities between
taxonomic compositions of carriage groups will prove valuable in future applications of this
model. Illumina MiSeq detections of V3-V4 amplicons of the 16S rRNA gene only allowed for
mostly genus-level identifications, therefore future inquiries into the pigtailed macaque and
human nasal microbiomes should implement a more sensitive method that can acquire specieslevel identifications.
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
Staphylococcus aureus nasal carriage is prevalent in at least 30% of the healthy world
population and presents a risk of autoinfection to the host and dissemination to new
immunocompromised hosts in nosocomial and at-risk communities. SANC is a dynamic state,
and is influenced by SA strain genetics, host immune responses, and the nasal mucosal
environment, which is impacted by factors like climate, health of the host, and non-SA
commensals. The mechanisms that impact SANC are not fully understood as it results from
complex interactions, and the lack of a human-relevant model prevents further study due to the
ethical and procedural limitations set for human research. Historically implemented rodent
models for SANC do not translate well to the human condition as they resist enormous nasal
inoculations, resulting in only transient carriage.

Murine immune responses lack key

components that play primary roles in the human’s heavily neutrophilic response to SA
inoculations, and instead clear the nostrils through T cell mediation. Longitudinal studies are
impossible with rodent models due to their small size, however SANC is very individualized,
and longitudinal sampling is necessary to understand immune and nasal commensal responses to
inoculations. Transitions of potential therapeutics to clinical trials from rodent models often fail,
therefore development of an improved model is necessary for future research and clinical trials
of novel antibiotics to combat the rapid evolution of SA antibiotic resistance.
Unlike rodents, pigtailed macaques naturally carry SA in the nose and throat and are
easily decolonized of SA with 2% mupirocin topical antibiotic following an identical protocol
used to clear the nostrils and subsequently the body of pre-surgical humans.

Nasal and

extranasal carriage was established in all six animals with a human-relevant inoculation of 104
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CFUs per nostril of a variety of strains, with the nasal environment serving as a suitable reservoir
for passive transmission of the same strain to the rest of the body. This important aspect
provides a route around a significant limitation to human SANC studies, as in human SANC
studies, only self-strains are ethically permitted for inoculation and must be self-applied by the
subject. Acquisition and retention of human hosts for SANC studies has proven difficult as
humans have free-will and are unpredictable, and in the absence of symptoms, the return to a
laboratory for nasal swabs and nasal fluid collections becomes a burden and subjects are
frequently lost from studies.

This cohort of captive pigtailed macaques are maintained in

individual enclosures with climate and humidity control, and are treated and fed the same, which
eliminates the free-will aspect of study subjects as well as many environmental factors that can
impact SANC. Additionally, this sufficient low inoculum size of 104 CFUs per nostril is a
significant finding because in rodent models, only transient carriage of only a few days is
established with enormous inoculations in a much smaller nose, even when antibiotics are added
to drinking water to inhibit competition from nasal microbiome inhabitants. Further modeling
the human condition of SANC, pigtailed macaque nostrils maintain the highest density of SA,
which is an aspect not observed in rodent models of carriage. A three-week pilot study found
that a human SA isolate shared genetic similarity to macaque isolates and nasal colonization was
just as easily accomplished with the same inoculum size in this model as inoculations with
various macaque SA strains.

Once established, SANC in the pigtailed macaque is easily

followed longitudinally with a simple nasal swab, a convenience that is lacking in rodent models,
which results in the sacrifice of a large number of rodents, often without any benefit as many will
clear SA rapidly from the nose. Carriage patterns in healthy pigtailed macaques model the
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human well, and present as mostly intermittent with some individuals able to clear SA from the
nostrils naturally while others maintain persistent carriage.
Macaques that were able to clear the nostrils of SA displayed up-regulations of key proinflammatory mediators once SA was detected as compared to its absence. These proteins are
also up-regulated in the human response to SA and are associated with neutrophil recruitment
and maturation as well as exacerbation of the inflammatory response in the nasal mucosa. Key
neutrophil-associated pro-inflammatory proteins implicated in prior human research to mediate
clearance of SA from the nasal mucosa were found to play important roles in the pigtailed
macaque as well, also not modeled in even the most relevant rodent model. In macaques that
were able to clear SA from the nose, IL-8, IL-1β, and MCP-1 were significantly up-regulated in
the nasal mucosa as detected through multi-plex bead assays of nasal fluids, as well as a 10-fold
decrease in the IL-1RA: IL-1β ratio. These up-regulations were not detected in the serum, and
when paired with husbandry charts indicate that SANC in the pigtailed macaque is asymptomatic
as it in the human condition. Animals that maintained persistent carriage failed to establish this
required shift in pro-inflammatory expression similar to human persistent carriers. Carriage
duration correlated with temporal peaks in IL-8 and IL-1β expression, the earlier the peak the
more quickly clearance occurred. Animals that failed to accomplish a peak in expression or the
peak occurred at 16 days or later maintained carriage for significantly longer or were
unsuccessful in clearance of SA. This data suggested that as in humans, dysregulation of factors
involved in neutrophil recruitment and function in the pigtailed macaque nasal mucosa leads to
prolonged duration of carriage and/or inability to clear SA from the nose.
Pigtailed macaques and humans host similar microbes in the nose as determined through
both culturable methods and MiSeq analysis of representative swabs samples collected
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longitudinally,

with

similar

relative

abundance

of

taxa,

namely

Staphylococcal,

Corynebacterium, Dolosigranulum, and Acinetobacter. Species in the Acinetobacter genus may
correlate to a shortened duration of SANC rather than previously implicated Corynebacterium,
which was present in all samples. Like humans, pigtailed macaques support diverse genera in
the nose, and the nasal microbiome appears to act as an additional major factor of SANC
observed by notable differences in abundances observed between carrier and non-carrier groups.
This is the first study of its type to implement the pigtailed macaque in SA nasal
inoculation studies, and these significant findings reveal great future potential applications for
this model. Since these animals naturally carry SA in the nose and throat, they would be useful
as a decolonization model for newly developed antimicrobials against SA that would not
necessarily require inoculations of SA, but a simple screening process to determine carriage
status. Through a series of directed inoculation studies, it was found that a variety of SA strains
could establish carriage and persist in the nostrils, including a human nasal isolate.

This

indicates the likelihood for a wide variety of SA strains to successfully establish carriage,
including potentially antibiotic resistant and virulent strains, providing a potential way to
circumvent this limitation placed on human SANC studies. Longitudinal follow-up of SANC
would be useful in conjunction with pro-inflammatory protein detections of corresponding days
to observe human-relevant immune responses to virulent SA. In addition to SANC, considering
the MiSeq analysis of the nasal microbiome revealed similarities in bacterial species and their
relative abundances, proposed inhibitors of SA like Corynebacterium and Acinetobacter species
could be introduced into the nostrils to correlate not only to duration of carriage, but also
changes in SA gene expression in a living model as these kinds of studies have mostly taken
place in vitro.
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In terms of possibilities for future application of this project specifically, the second
aliquot of nasal fluids analyzed through multi-plex bead assays are reserved, with potential for
future detections of additional factors of SANC, such as defensins that could be correlated to the
data already discussed herein. The acid extracted nasal fluids of only one nostril were assayed
for ten potential mediators in the inflammatory response, therefore the protein laden nasal strips
corresponding to the opposite nostril are still reserved at -80°C and could be extracted and
assayed for the analytes found significant in this study in addition to others. Also remaining at 80°C are representative glycerol stocks of the swab samples collected from the nostrils not
implemented in the Illumina MiSeq microbiome analyses that could be analyzed using more
sensitive metagenomic detections to identify down to the species level. With this model, knock
out studies of adhesion proteins, virulence factors, and more could be performed, and elucidate
mechanisms that have not been available for in vivo study thus far. Future directions of this
laboratory in implementation of the pigtailed macaque as a human-relevant model for SANC aim
to specifically focus on longitudinal analyses including: internalization of SA in nasal mucosal
cells, SA genome evolution, and alterations in SA protein expression as it progresses from
establishing adhesion and colonization to once prolonged nasal carriage is established. These
analyses will increase understanding of other factors that may allow SA to persist through
multiple methods of evading the immune system.
Together, these multi-dimensional analyses of the potential for the pigtailed macaque,
Macaca nemestrina, as a model for human SANC demonstrate that they are much improved as
compared to historic rodent models. As Staphylococcus aureus continues its rapid evolution of
antibiotic resistance to every medication used to combat infections, a new model is crucial for
discovery and development of novel therapies with the hopes of increased potential for success
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in clinical trials. SANC is a highly dynamic and individualized state impacted by a multitude of
factors that are not fully understood yet. In terms of human studies, the science has progressed
as far as it can to elucidate dynamics between SA and the host immune system. Further
understanding of the relationship between SA and the resident nasal microbiome, elucidating
methods of immune evasion, and identifying shifts in SA protein expression is necessary for
progressive intervention strategies.

Circumvention of experimental and ethical limitations

placed on human SANC research implementing the pigtailed macaque would better scientific
knowledge on this multifactorial state and ease the burden on healthcare with improved
decolonization strategies in nosocomial and at-risk community settings.
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